Center for Infectious Disease Research And Policy
 Home  _  Mission & Activities  _  About Us  _  Center Support  _  Contact Us 
 
Influenza
  
_
General Info/
Vaccines
Influenza
  
_
Avian Flu
  _ _
   _    News
  _ _
   _    Overview
  _ _
   _    Case Count
  _ _
   Current item    Selected Reading
  _ _
   _    Guidelines
  _ _
   _    More Links
  _ _
Influenza
  
_
Pandemic Flu
Influenza
  
_
Business Planning
Influenza
Bioterrorism
  
_
General Info
Bioterrorism
  
_
Anthrax
Bioterrorism
  
_
Botulism
Bioterrorism
  
_
Plague
Bioterrorism
  
_
Smallpox
Bioterrorism
  
_
Tularemia
Bioterrorism
  
_
VHF
Bioterrorism
Biosecurity
  
_
Agriculture
Biosecurity
  
_
Food
Biosecurity
Food Safety
  
_
General Info
Food Safety
  
_
Irradiation
Food Safety
  
_
Foodborne Disease
Food Safety
Other Topics
  
_
BSE & vCJD
Other Topics
  
_
SARS
Other Topics
  
_
West Nile
Other Topics
  
_
Monkeypox
Other Topics
  
_
Chemical Terrorism
Other Topics
_
_
Influenza

INFLUENZA >>  AVIAN INFLUENZA >> 

_
Selected Reading  

* Aamir UB, Wernery U, Ilyushina N, et al. Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003. Virology 2007 Apr 25;361(1):45-55 [Abstract]

* Abbate R, Di Giuseppe G, Marinelli P, et al. Knowledge, attitudes, and practices of avian influenza, poultry workers, Italy. Emerg Infect Dis 2006 Nov;12(11) (published online Oct 13) [Full text]

* Abbott A. Chicken flu races through Dutch poultry farms. Nature 2003 Mar 20;422(6929):247 [Full text]

* Acambis. Acambis enters flu vaccine arena with launch of flu vaccine development programme. Aug 4, 2005 [Full Text]

* Aiki-Raji CO, Aguilar PV, Kwon YK, et al. Phylogenetics and pathogenesis of early avian influenza viruses (H5N1), Nigeria. Emerg Infect Dis 2008 Nov;14(11):1753-5 [Full text]

* Al-Azemi A, Bahl J, Al-Zenki S, et al. Avian influenza A virus (H5N1) outbreaks, Kuwait, 2007. Emerg Infect Dis 2008 Jun;14(6):958-62 [Full text]

* Alexander DJ. Should we change the definition of avian influenza for eradication purposes? Avian Dis. 2003;47(3 Suppl):976-81 [Abstract]

* Alibek K, Liu G. Biodefense shield and avian influenza. (Letter) Emerg Infect Dis 2006 May;12(5):873-5 [Full text]

* Altiok E, Taylan F, Yenen OS, et al. Mutations in influenza A virus (H5N1) and possible limited spread, Turkey, 2006. Emerg Infect Dis 2008 Mar;14(3) (published online Feb 4) [Full text]

* Aly MM, Arafa A, Hassan MK. Epidemiological findings of outbreaks of disease caused by highly pathogenic H5N1 avian influenza virus in poultry in Egypt during 2006. Avian Dis 2008 Jun;52(2):269-77 [Abstract]

* American Council on Science and Health. Avian influenza, or bird flu: what you need to know. Mar 2006 [Full text]

* Amonsin A, Choatrakol C, Lapkuntod J, et al. Influenza virus (H5N1) in live bird markets and food markets, Thailand. Emerg Infect Dis 2008 Nov;14(11) (published online Oct 16) [Full text]

* Ao Z, Patel A, Tran K, et al. Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules. Antiviral Res 2008 Jul;97(1):12-18 [Abstract]

* Apisarnthanarak A, Mundy LM. Antiviral therapy for avian influenza virus (H5N1) infection at 2 Thai medical centers: survey findings and implications for pandemic preparedness. Infect Control Hosp Epidemiol 2008;29 (published online Oct 30) [Abstract]

* Apisarnthanarak A, Erb S, Stephenson I, et al. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin Infect Dis 2004 Jan 15;40(2):e16-8 [Full text]

* Apisarnthanarak A, Kitphati R, Thongphubeth K, et al. Atypical avian influenza (H5N1). Emerg Infect Dis 2004 Jul;10(7):1321-4 [Full text]

* Apisarnthanarak A, Puthavathana P, Kitphati R, et al. Avian influenza H5N1 screening of intensive care unit patients with community-acquired pneumonia. Emerg Infect Dis 2006;12(11) (published online Oct 5) [Full text]

* Apisarnthanarak A, Warren DK, Fraser VJ. Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries. Clin Infect Dis 2007 Nov 15;45(10):1338-42 [Abstract]

* Areechokchai D, Jiraphongsa C, Laosiritaworn Y, et al. Investigation of avian influenza (H5N1) outbreak in humans: Thailand, 2004. MMWR 2006 Apr 28;55(Suppl 1):3-6 [Full text]

* Arizona Department of Health Services. Modern Methods for Influenza Detection and Sub-typing [PowerPoint presentation]

* ASTHO. Nature's terrorist attack: pandemic influenza. Preparedness planning for state health officials. Nov 2002 [Full text]

* Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135?42 [Abstract]

* Auewarakul P, Sangsiriwut K, Chaichoune K, et al. Surveillance for reassortant virus by multiplex reverse transcription-PCR specific for eight genomic segments of avian influenza A H5N1 viruses. J Clin Microbiol 2007 May;45(5):1637-9 [Abstract]

* Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 2007 Sep;81(18):9950-5 [Abstract]

* Australian Government Department of Health and Ageing. Influenza laboratory case definition [Full text]

* Ayyalasomayajula S, DeLaurentis DA, Moore GE, et al. A network model of H5N1 avian influenza transmission dynamics in domestic cats. Zoonoses Public Health 2008 (published online Jul 9) [Abstract]

* Balicer RD, Reznikovich S, Berman E, et al. Tackling a multifocal avian influenza (H5N1) outbreak. Emerg Infect Dis 2007 Oct;13(10):1601-3 [Full text]

* Balkhy H. Avian influenza: the tip of the iceberg. Ann Thorac Med 2008 Oct-Dec;3(4):154-7 [Full text]

* Bansal S, Pourbohloul B, Meyers LA. A comparative analysis of influenza vaccination programs. PLoS Med 2006 Oct;3(10) [Full text]

* Baras B, Stittelaar KJ, Simon JH, et al. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS ONE 2008 Jan 2;3(1):e1401 [Full text]

* Barbazan P, Thitithanyanont A, Misse D, et al. Detection of H5N1 avian influenza virus from mosquitoes collected in an infected poultry farm in Thailand. Vector Borne Zoonotic Dis 2008 Feb;8(1):105-110 [Abstract]

* Barennes HM, Martinez-Aussel B, Vongphrachanh P, et al. Avian influenza risk perceptions, Laos. (Letter) Emerg Infect Dis 2007 Jul;13(7):1126-8 [Full text]

* Barral M, Alvarez V, Juste R, et al. First case of highly pathogenic H5N1 avian influenza virus in Spain. BMC Vet Res 2008 Dec 10;4:50 [Abstract]

* Barrett R, Brown PJ. Stigma in the time of influenza: social and institutional responses to pandemic emergencies. J Infect Dis 2008 Feb 15;197(S1):S34-7 [Abstract]

* Bartlett JG. Planning for avian influenza. Ann Intern Med 2006 Jul 18;145(2) (published online Jun 27) [Full text]

* Basler CF, Aguilar PV. Progress in identifying virulence determinants of the 1918 H1N1 and Southeast Asian H5N1 influenza viruses. Antiviral Res 2008 Sep;78(3):166-78 [Abstract]

* Beach RH, Fred Kuchler F, Leibtag E, et al. The effects of avian influenza news on consumer purchasing behavior: a case study of Italian consumers' retail purchases. Econ Res Rep 2008 Aug 29 (report no. ERR-65) [Full text]

* Beato MS, Toffan A, De Nardi R, et al. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1. Vaccine 2007 May 16;25(20):4064-72 [Abstract]

* Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102 [Abstract]

* Belser JA, Blixt O, Chen LM, et al. Contemporary North American influenza H7 viruses possess human receptor specificity: implications for virus transmissibility. Proc Natl Acad Sci 2008 (published online May 27) [Full text]

* Belser JA, Lu X, Maines TR, et al. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol 2007 Oct;81(20):11139-47 [Abstract]

* Belser JA, Lu X, Szretter KJ, et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis 2007 Nov 15;196(10):1493-9 [Abstract]

* Benitez MA. Hong Kong's health policies focus on containing avian influenza. Lancet 2003 Jan 25;361(9354):318

* Bernstein DI, Edwards KM, Dekker CL, et al. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J Infect Dis 2008 Mar 1;197(suppl 2):667-75 [Abstract]

* Bertelsen MF, Klausen J, Holm E, et al. Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine. Vaccine 2007 May 30;25(22):4345-9 [Abstract]

* Biswas PK, Christensen JP, Ahmed SSU, et al. Avian influenza outbreaks in chickens, Bangladesh. Emerg Infect Dis 2008 Dec;14(12) (published online Oct 31) [Full text]

* Boender GJ, Hagenaars TJ, Bouma A, et al. Risk maps for the spread of highly pathogenic avian influenza in poultry. PLoS Comp Biol 2007 Apr;3(4):e71 [Full text]

* Bogner P, Capua I, Cox, NJ, et al. A global initiative on sharing avian flu data. Nature 2006 (Published online Aug 24) [Full text]

* Boltz DA, Douangngeun B, Sinthasak S, et al. H5N1 influenza viruses in Lao People's Democratic Republic. Emerg Infect Dis 2006 Oct;12(10):1593-5 [Full text]

* Boltz DA, Rehg JE, McClaren J, et al. Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model. J Infect Dis 2008 May 1;197(9):1315-23 [Abstract]

* Boon ACM, Sandbulte MR, Seiler P, et al. Role of terrestrial wild birds in ecology of influenza A virus (H5N1). Emerg Infect Dis 2007 Nov:1720-4 [Full text]

* Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31 [Abstract]

* Bosman A, Meijer A, Koopmans M. Final analysis of Netherlands avian influenza outbreaks reveals much higher levels of transmission to humans than previously thought. Eurosurveillance Weekly 2005 Jan 6;10(1) [Full text]

* Boyce W. Earth monitoring: vigilance is not enough. Nature 2007 Dec 6;450(7171):791-2 [Full text]

* Bresson JL, Perrone C, Launay O, et al. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet 2006 May 20;367(9523):1657-64 [Abstract]

* Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7 [Full text]

* Bright RA, Carter DM, Crevar CJ, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 2008 Jan 30;3(1):e1501 [Full text]

* Bright RA, Medina M, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005 Oct 1;366(9492):1175-81 [Abstract]

* Brown C, Horstick O, Naville F, et al. Avian influenza outbreaks in the WHO European region and public health actions. Eurosurveillance Weekly 2005 Oct 27;10(10) [Full text]

* Brown C, Paget J, Meijer A. Avian influenza: current situation in southeast Asia and impact on Europe. Eurosurveillance Weekly 2005 Jan 20 [Full text]

* Brown JD, Stallknecht DE, Beck JR, et al. Susceptibility of North American ducks and gulls to H5N1 highly pathogenic avian influenza viruses. Emerg Infect Dis 2006 Nov;12(11) (published online Oct 13) [Full text]

* Brown JD, Stallknecht DE, Swayne DE. Experimental infection of swans and geese with highly pathogenic avian influenza virus (H5N1) of Asian lineage. Emerg Infect Dis 2008 Jan;14(1):136-42 (published online Dec 21) [Full text]

* Brown JD, Stallknecht DE, Swayne DE. Experimental infections of herring gulls (Larus argentatus) with H5N1 highly pathogenic avian influenza viruses by intranasal inoculation of virus and ingestion of virus infected chicken meat. Avian Pathol 2008 Aug;37(4):393-7 [Abstract]

* Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10):e401 [Full text]

* Budd A, Alleva L, Alsharifi M, et al. Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob Agents Chemother 2007 Aug;51(8):2965-8 [Abstract]

* Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51 [Abstract]

* Butler D. Q&A: Siti Fadilah Supari. Nature 2007 Dec 20;450(7173):1137 [Full text]

* Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza? JAMA 2005 Feb 23;293(8):987-97 [Astract]

* Cameron CM, Cameron MJ, Bermejo-Martin JF, et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J Virol 2008 Nov;82(22):11308-17 [Abstract]

* Campitelli L, Di Martino A, Spagnolo D, et al. Molecular analysis of avian H7 influenza viruses circulating in Eurasia in 1999-2005: detection of multiple reassortant virus genotypes. J Gen Virol 2008 Jan;89(1):48-59 [Abstract]

* Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol. 2004 Aug;33(4):393-404 [Abstract]

* Capua I, Alexander DJ. Ecology, epidemiology and human health implications of avian influenza viruses: why do we need to share genetic data? Zoonoses Publ Health 2008 Feb;55(1):2-15 [Abstract]

* Capua I, Marangon S. Control and prevention of avian influenza in an evolving scenario. Vaccine 2007 Jul 26;25(30):5645-52 [Abstract]

* Capua I, Marangon S. Control of avian influenza in poultry. Emerg Infect Dis 2006 Sep 2006;12(9) [Full text]

* Capua I, Marangon S. The use of vaccination to combat mutiple introductions of notifiable avian influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy. Vaccine 2007 Jun 28;25(27):4987-95 [Abstract]

* Capua I, Marangon S. Vaccination in the control of avian influenza in the EU. Vet Rec 2003 Mar 1;152(9):271

* Carter NJ, Plosker GL. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) (Prepandrix): a review of its use as an active immunization against influenza A subtype H5N1 virus. BioDrugs 2008;22(5):279-82 [Abstract]

* Cattoli G, Terregino C. New perspectives in avian influenza diagnosis. Zoonoses Publ Health 2008 Feb;55(1):24-8 [Abstract]

* CDC. Avian Influenza A Viruses [Webpage]

* CDC. Cases of influenza A (H5N1): Thailand, 2004. MMWR 2004 Feb 13;53(5):100-3 [Full text]

* CDC. Guidelines and recommendations: interim guidance about avian influenza (H5N1) for U.S. citizens living abroad. Outbreak notice updated Nov 3, 2008 [Full text]

* CDC. Human infection with avian influenza A (H5N1) virus: advice for travelers. Outbreak notice updated Nov 3, 2008 [Full text]

* CDC. Information about influenza A H7 viruses. Feb 12, 2004 [Full text]

* CDC. Interim CDC-NIH recommendation for raising the biosafety level for laboratory work involving noncontemporary human influenza (H2N2) viruses. Excerpted from draft: Biosafety in microbiological and biomedical laboratories. Ed 5. May 3, 2005 [Full text]

* CDC. Interim guidance about avian influenza A (H5N1) for U.S. citizens living abroad. Updated frequently [Full text]

* CDC. Interim guidance for airline cleaning crew, maintenance crew, and baggage/package and cargo handlers for airlines returning from areas affected by avian influenza A (H5N1). Updated frequently [Full text]

* CDC. Interim guidance for airline flight crews and persons meeeting passengers arriving from areas with avian influenza. Published Feb 18, 2004; updated frequently [Web page]

* CDC. Interim guidance for protection of persons involved in U.S. avian influenza outbreak disease control and eradication activities. Feb 17, 2004 [Full text]

* CDC. Interim guidance for states conducting avian mortality surveillance for West Nile virus (WNV) and/or highly pathogenic H5N1 avian influenza virus. Released Aug 23, 2006 [Full text]

* CDC. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza [Webpage]

* CDC. Interim recommendations for persons with possible exposure to avian influenza during outbreaks among poultry in the United States. Feb 24, 2004 [Web page]

* CDC. Key facts about avian influenza (bird flu) and avian influenza A (H5N1) virus. Updated Dec 28, 2005 [Full text]

* CDC. Lab diagnosis. [Webpage]

* CDC. New laboratory assay for diagnostic testing of avian influenza A/H5 (Asian lineage). MMWR 2006 Feb 3;55(Early release):1 [Full text]

* CDC. Outbreak notice: Human infection with avian influenza A (H5N1) virus in Asia. Travel recommendations. Published Sep 23, 2005; updated frequently [Full text]

* CDC. Traveler's health: Illness abroad [Webpage]

* CDC. Traveler's health: Traveler's health kit [Webpage]

* CDC. Travelers' Health [Webpage]

* CDC. Update on influenza A(H5N1) and SARS: Interim recommendations for enhanced U.S. surveillance, testing, and infection controls [Full text]

* CDC. Updated interim guidance for laboratory testing of persons with suspected infection with avian influenza A (H5N1) virus in the United States. Jun 7, 2006 [Full text]

* Chaichoune K, Wiriyarat W, Thitithanyanont A, et al. Indigenous sources of 2007 -2008 H5N1 influenza outbreaks in Thailand. J Gen Virol 2009 Jan;90(1):216-22 [Abstract]

* Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005 Nov 11;6(1) [Full text]

* Chan PK. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infec Dis 2002;34:Suppl 2:S58-S64

* Chandrasekaran A, Srinivasan A, Raman R, et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 2008 Jan;26(1):107-13 [Abstract]

* Chen GW, Chang SC, Mok CK, et al. Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis 2006 Sep;12(9):1353-60 [Full text]

* Chen H, Deng G, Li Z, et al. The evolution of H5H1 influenza viruses in ducks in southern China. Proc Natl Acad Sci 2004 Jul 13;101(28):10452-7 [Full text]

* Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci 2006 (published online Feb 10) [Abstract]

* Chen H, Smith GJ, Zhang SY, et al. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 2005 Jul 14;436(7048):191-2 [First paragraph]

* Chen J, Chen SCY, Stern P, et al. Genetic strategy to prevent influenza virus infections in animals. J Infect Dis 2008 Feb 15;197(S1):S25-8 [Abstract]

* Chen J, Yang Z, Chen Q, et al. Characterization of H5N1 influenza A viruses isolated from domestic green-winged teal. Virus Genes 2008 (published online Sep 30) [Abstract]

* Chen JM, Chen JW, Dai JJ, et al. A survey of human cases of H5N1 avian influenza reported by the WHO before June 2006 for infection control. Am J Infect Control 2007 Jun;35(5);351-3 [Abstract]

* Chen LM, Davis CT, Zhou H, et al. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog 2008 May 23;4(5):e1000072 [Full text]

* Chen MW, Cheng TJR, Huang Y, et al. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci 2008 (published online Sep 2) [Abstract]

* Chen X, Smith GJD, Zhou B, et al. Avian influenza A (H5N1) infection in a patient in China, 2006. Influenza Other Resp Viruses 2007 Sep/Nov;1(5-6):207-13 [Full text]

* Chen Y, Qin K, Wu WL, et al. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. J Infect Dis 2008 (published online Nov 25) [Abstract]

* Chen Y, Xu F, Fan X, et al. Evaluation of a rapid test for detection of H5N1 avian influenza. J Virol Methods 2008 (published online Sep 12) [Abstract]

* Chen Z, Santos C, Aspelund A, et al. Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets. J Virol 2009 Jan;83(1):65-72 [Abstract]

* Cheng LS, Amaro RE, Xu D, et al. Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. J Med Chem 2008 (published online Jun 18) [Abstract]

* Cheng X, Wu C, He J, et al. Serological and genetic characterization analyses of a highly pathogenic influenza virus (H5N1) islolated from an infected man in Shenzhen. J Med Virol 2008 Apr 21;80(6):1058-64 [Abstract]

* Cheung C-L, Rayner JM, Smith GJD, et al. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis Jun 15 2006;193(12):1626-9 [Abstract]

* Cheung CL, Vijaykrishna D, Smith GJD, et al. Establishment of influenza A virus (H6N1) in minor poultry species in Southern China. J Virol 2007 Oct;81(19):10402-12 [Abstract]

* Choi YK, Ozaki H, Webby RJ, et al. Continuing evolution of H9N2 influenza viruses in southeastern China. J Virol 2004 Aug;78(16):8609-14 [Abstract]

* Chotpitayasundondh T, Thisyakorn U, Pancharoen C, et al. Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children. PLoS ONE 2008 Dec 29;3(12):e4028 [Full text]

* Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005 Feb;11(2) [Full text]

* Christian MD, Hawryluck L, Wax RS, et al. Development of a triage protocol for critical care during an influenza pandemic. CMAJ 2006 Nov 21;175(11):1377-81 [Full text]

* Chutinimitkul S, Bhattarakosol P, Srisuratanon S, et al. H5N1 influenza A virus and infected human plasma. (Letter) Emerg Infect Dis 2006 Jun;12(6 [Full text]

* Chutinimitkul S, Songserm T, Amonsin A, et al. New strain of influenza A virus (H5N1), Thailand. (Letter) Emerg Infect Dis 2007 Mar;13(3) (published online Feb 15) [Full text]

* Cinatl J Jr, Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part IV: development of vaccines. Med Microbiol Immunol 2007 (published online Jun 1) [Abstract]

* Coiras MT, Perez-Brena P, Garcia ML, et al. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J Med Virol 2003 Jan;69(1):132-44 [Abstract]

* Collins PJ, Haire LF, Lin YP, et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008 Jun 26;453(7199):1258-61 [Abstract]

* Collins RA, Ko LS, Fung KY, et al Rapid and sensitive detection of avian influenza virus subtype H7 using NASBA. Biochem Biophys Res Commun 2003 Jan 10;300(2):507-15 [Abstract]

* Conenello GM, Zamarin D, Perrone LA, et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007 Oct 5;3(10):e141 [Full text]

* Coombes R. Hunting down the H5N1 virus. BMJ 2007 Feb 17;342(7589):342-3 [Abstract]

* Couacy-Hymann, Danho T, Keita D, et al. The first specific detection of a highly pathogenic avian influenza virus (H5N1) in Ivory Coast. Zoonoses Public Health 2008 (published online Aug 14) [Abstract]

* Crevar CJ, Ross TM. Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. Virol J 2008 Oct 28;5(1):131 [Abstract]

* Crofts J, Paget J, Karcher F. H5N1 avian influenza virus: human cases reported in southern China. Eurosurveillance Weekly 2003 Feb 9;7(9) [Full text]

* Cui S, Tong G. A chromatographic strip test for rapid detection of one lineage of the H5 subtype of highly pathogenic avian influenza. J Vet Diagn Invest 2008 Sep;20(5):567-71 [Abstract]

* Curran MS, Ellis JS, Wreghitt TG, et al. Establishment of a UK National Influenza H5 Laboratory Network. J Med Microbiol 2007 Oct;56(10):1263-7 [Full text]

* Daidoji T, Koma T, Du A, et al. H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells. J Virol 2008 Nov;82(22):11294-307 [Abstract]

* Dalla Pozza M, Ceolin C, Marangon S. Emergency response following suspicion of an avian influenza outbreak. Zoonoses Publ Health 2008 Feb;55(1):50-3 [Abstract]

* Dawson ED, Moore CL, Smagala JA, et al. MChip: a tool for influenza surveillance. Anal Chem Nov 15;78(22):7610-5 [Abstract]

* De Clercq E. Antiviral agents active against influenza A viruses. Nature Rev Drug Disc 2006 Dec;5(12):1015-25 [Abstract]

* De Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. (Letter) Nat Med 2006 Oct:12(10):1203-7 [Abstract]

* De Jong MD, Thanh TT, Khank TH, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005 Dec 22;353(24):2667-72 [Full text]

* De Jong MD, Van Cam B, Qui PT, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005 Feb 17;352:686-91 [Abstract]

* de Wit E, Kawaoka Y, de Jong MD, et al. Pathogenicity of highly pathogenic avian influenza virus in mammals. Vaccine 2008 Sep 12;26(suppl 4):D54-8 [Full text]

* de Zwart O, Veldhuijzen IK, Elam G, et al. Avian influenza risk perception, Europe and Asia. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 10) [Full text]

* DEFRA (UK Dept for Environment, Food and Rural Affairs). H5N1 highly pathogenic avian influenza outbreak, Holton, Suffolk, February 2007: lessons to be learned report. Released Oct 11, 2007 (but dated Aug 3) [Full text]

* DEFRA (UK Dept for Environment, Food and Rural Affairs). Highly pathogenic avian influenza H5N1 in wild swans in Dorset. Epidemiology report released Jan 30, 2008 [Full text]

* DEFRA (UK Dept for Environment, Food and Rural Affairs). Outbreak of Highly Pathogenic H5N1 Avian Influenza in Suffolk in January 2007: A Report of the Epidemiological Findings by the National Emergency Epidemiology Group, Defra. Released Apr 19, 2007 [Full text]

* Dent JE, Kao R, Kiss IZ, et al. Contact structures in the poultry industry in Great Britain: exploring transmission routes for a potential avian influenza virus epidemic. BMC Vet Res 2008 Jul 23;4:27 [Abstract - with link to full text]

* Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007 Jul 15;196(2):249-57 [Full text]

* Di Giuseppe G, Abbate R, Albano L, et al. A survey of knowledge, attitudes and practices towards avian influenza in an adult population of Italy. BMC Infect Dis 2008 Mar 17;8:36 [Abstract, with link to full text]

* DiNapoli JM, Yang L, Suguitan A Jr, et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza. J Virol 2007 Nov;81(21):11560-8 [Abstract]

* Dinh PN, Long HT, Tien NTK, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 2006;12(12) (published online Oct 25) [Full text]

* Dogan N, Ozkan B, Boga I, et al. A successful treatment of avian influenza infection in Turkey. J Trop Pediatr 2008 (published online Nov 13) [Abstract]

* Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. (Commentary) J Clin Invest 2008 (published online Sep 18) [Full text]

* Dolberg F. Emergency regional support for post-avian influenza rehabilitation. From FAO. Feb 2005 [Full text]

* Du QS, Wang SQ, Chou KC. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Comm 2007 (published online Aug 13) [Abstract]

* Duan L, Bahl J, Smith GJD, et al. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virology 2008 Oct 25;380(2):243-254 [Abstract]

* Duan L, Campitelli L, Fan XH, et al. Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses. J Virol 2007 Jul;81(14):7529-39 [Abstract]

* Ducatez MF, Olinger CM, Owoade AA, et al. Avian flu: multiple introductions of H5N1 in Nigeria. (Brief Communications) Nature 2006 Jul 6;442(7098):37 [Full text]

* Ducatez MF, Olinger CM, Owoade AA, et al. Molecular and antigenic evolution and geographical spread of H5N1 highly pathogenic avian influenza viruses in western Africa. J Gen Virol 2007 Aug;88(8):2297-306 [Abstract]

* Ducatez MF, Tarnagda Z, Tahita MC, et al. Genetic characterization of HPAI (H5N1) viruses from poultry and wild vultures, Burkina Faso. Emerg Infect Dis 2007 Apr;13(4) (published online Mar 19) [Full text]

* Dugan VG, Chen R, Spiro DJ, et al. The evolutionary genetics and emergence of avian influenza viruses in wild birds. PLoS Pathog 2008 May 30;4(5):e1000076 [Full text]

* Duwe S, Schweiger B. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Method 2008 (published online Aug 22) [Abstract]

* Economist staff. Bird flu in Asia: coming home to roost? Economist 2007 (published online Jan 25) [Full text]

* Editorial team. Avian influenza A/(H7N2) outbreak in the United Kingdom. Eurosurveillance Weekly 2007 May 31;12(5):E070531.2 [Full text]

* Edwards JC, Kang J, Silenas R. Promoting regional disaster preparedness among rural hospitals. J Rural Health 2008 Summer;24(3):321-5 [Abstract]

* Edwards S. OFFLU network on avian influenza. Emerg Infect Dis 2006 Aug;12(8) [Full text]

* EFSA (European Food Safety Authority). Animal health and welfare aspects of avian influenza and the risk of its introduction into the EU poultry holdings--scientific opinion of the Panel on Animal Health and Welfare. Report released May 7, 2008 [Full text]

* EFSA (European Food Safety Authority). Update on avian influenza and food safety. Oct 26, 2005 [Press release]

* Ehrlich HJ, Muller M, Oh HML, et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 2008 Jun 12;358(24):2573-84 [Full text]

* Eichelberger M, Golding H, Hess M, et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12;26(34):4299-303 [Abstract]

* Ellis JS, Smith JW, Braham S, et al. Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans. J Clin Microbiol 2007 May;45(5):1535-43 [Abstract]

* Enserink M. Influenza: tense meeting produces some hope for flu-sharing deal. Science 2007 Nov 30;318(5855):1361 [Abstract]

* Escorcia M, Vazquez L, Mendez ST, et al. Avian influenza: genetic evolution under vaccination pressure. Virol J 2008 Jan;5:15 (published online Jan 24) [Abstract]

* European Centre for Disease Prevention and Control Influenza Team. H5N1 infections in cats: public health implications. Eurosurveillance Weekly 2006 Apr 13;11(4) [Full text]

* European Centre for Disease Surveillance and Control. Highly pathogenic avian influenza A/H5N1--update and overview of 2006. Eurosurveillance Weekly 2006 Dec 21;11(12):E061221.1 [Full text]

* European Commission. Timeline of actions by the EC on avian influenza and human flu pandemic preparedness. Aug 25, 2005 [Full text]

* Eurosurveillance Editorial Team. Preventing introduction and spread of avian influenza among bird flocks in Europe: recommendations by European Animal Health Panel. Eurosurveillance Weekly 2005 Sep 29;10(9) [Full text]

* Fang LQ, de Vlas SJ, Liang S, et al. Environmental factors contributing to the spread of H5N1 avian influenza in mainland China. PLoS ONE 2008 May 28;3(5):e2268 [Full text]

* FAO. Avian influenza background. Animal Health Special Report (Includes map of poultry density in Southeast Asia) [Web page]

* FAO. Avian influenza in cats should be closely monitored. Recommendations released Feb 8, 2007 [Full text]

* FAO. Bird flu situation in Indonesia critical. Report released Mar 18, 2008 [Full text]

* FAO. Enhancing control of highly pathogenic avian influenza in developing countries through compensation: issues and good practice. Nov 27, 2006 [Full text]

* FAO. H5N1 in cats. Mar 7, 2006 [Full text]

* FAO. Potential risk of highly pathogenic avian influenza (HPAI) spreading through wild water bird migration. FAOAIDEnews 2005 Sep 1;33 [Full text]

* FAO. Understanding avian influenza. Overview released Apr 7, 2008 [Full text]

* FAO. Update on the avian influenza situation. AIDE News 2006 Jun 19, Issue no. 40 [Full text]

* FAO/WHO. Highly pathogenic H5N1 avian influenza outbreaks in poultry and in humans: food safety implications. Nov 4, 2005 [Full text]

* Fasina FO, Bisschop SP, Joannis TM, et al. Molecular characterization and epidemiology of the highly pathogenic avian influenza in H5N1 in Nigeria. Epidemiol Infect 2008 (published online Jul 17) [Abstract]

* Fasina FO, Bisschop SP, Webster RG. Avian influenza H5N1 in Africa: an epidemiological twist. Lancet Infect Dis 2007 Nov;7(11):696-7 [Full text]

* Fasina FO, Meseko AC, Joannis TM, et al. Control versus no control: options for avian influenza H5N1 in Nigeria. Zoonoses Public Health 2007 Jun;54(5):173-6 [Abstract]

* Fazekas G, Martosne-Mendi R, Jankovics I, et al. Cross-reactive immunity in adult and elderly patients against clade 2 influenza A H5N1 virus strains induced by Fluval, a reverse genetic-derived adjuvanted H5N1 clade 1 prototype pandemic influenza vaccine. Clin Vaccine Immunol 2008 (published online Nov 19) [Abstract]

* FDA. FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. Apr 17, 2007, press release [Full text]

* Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis 2008 (published online Apr 16) [Abstract]

* Ferguson N. Poverty, death, and a future influenza pandemic. Lancet 2006 Dec 23;368(9554);2187-8 [Full text]

* Fielding R, Bich TH, Quang LN, et al. Live poultry exposures, Hong Kong and Hanoi, 2006. Emerg Infect Dis 2007 Jul;13(7):1065-7 [Full text]

* Fielding R, Lam WW, Ho EY, et al. Avian influenza risk perception, Hong Kong. Emerg Infect Dis 2005 May;11(5) [Full text]

* Finkelstein DB, Mukatira S, Mehta PK, et al. Persistent host markers in pandemic and H5N1 influenza viruses. J Virol 2007 (published online Jul 25) [Abstract]

* Flint PL. Applying the scientific method when assessing the influence of migratory birds on the dispersal of H5N1. Virol J 2007;4:132 (published online Dec 4) [Abstract]

* Fouchier RA, Schneeberger PM, Rozendaal FW, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 2004 Feb 3;101(5):1356-61 [Abstract]

* Fouchier RAM, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005 Mar;79(5):2814-22 [Abstract]

* FSSCC (Financial Services Sector Coordinating Council for Critical Infrastructure Protection and Homeland Security). Statement on preparations for "avian flu." Jan 24, 2006 [Full text]

* Gabriel G, Herwig A, Klenk HD. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog 2008 Feb 1;4(2):e11 [Full text]

* Gaglia MA Jr, Cook RL, Kraemer KL, et al. Patient knowledge and attitudes about avian influenza in an internal medicine clinic. Publ Health 2008 (published online Jan 16) [Abstract]

* Gaidet N, Cattoli G, Hammoumi S, et al. Evidence of infection by H5N2 highly pathogenic avian influenza viruses in healthy wild waterfowl. PLoS Pathog 2008 Aug 15;4(8):e1000127 [Abstract]

* Gaidet N, Dodman T, Caron A, et al. Avian influenza viruses in water birds, Africa. Emerg Infect Dis 2007 Apr;13(4) (published online Mar 9) [Full text]

* Gaidet N, Newman SH, Hagemeijer W, et al. Duck migration and past influenza A (H5N1) outbreak areas. (Letter) Emerg Infect Dis 2008 Jul;14(7):1164-5 [Full text]

* Gall-Recule GL, Briand FX, Schmitz A, et al. Double introduction of highly pathogenic H5N1 avian influenza virus into France in early 2006. Avian Pathol 2008 Feb;37(1):15-23 [Abstract]

* Gambotto A, Barrat-Boyes SM, de Jong MD, et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008 Apr 25;371(9622):1464-75 [Abstract]

* GAO (US Government Accountability Office). Avian influenza: USDA has taken important steps to prepare for outbreaks, but better planning could improve response. Released Jun 11, 2007 [Full text]

* Gao W, Soloff AD, Lu X, et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006 Feb;80(4):1959-64 [Abstract]

* Garcia-Sastre A, Whitley RJ. Lessons learned from reconstructing the 1918 influenza pandemic. J Infect Dis 2006 Nov 1;194(suppl 2):S127-32 [Abstract]

* Garske T, Clarke P, Ghani AC. The transmissibility of highly pathogenic avian influenza in commercial poultry in industrialized countries. PLoS One 2007 Apr;2(4):e349 [Full text]

* Gauthier-Clerc M, Lebarbenchon C, Thomas F. Recent expansion of highly pathogenic avian influenza H5N1: a critical review. Ibis 2007 (published online Mar 20) [Abstract]

* Gayer M, Watson JT, Connolly MA. Displaced populations and pandemic influenza. Lancet Infect Dis 2006 Dec;6(12):755-6 [Full text - Free registration required]

* Ge J, Deng D, Wen Z, et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007 Jan;81(1):150-8 [Abstract]

* Geeraedts F, Goutagny N, Hornung V, et al. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog 2008 Aug 29;4(8):e1000138 [Full text]

* Ghabili K, Shoja MM, Kamran P. Avian influenza knowledge, medical students, Iran. (Letter) Emerg Infect Dis 2008 Apr (published online Mar 5) [Full text]

* Giese M, Harder TC, Teifke JP, et al. Experimental infection and natural contact exposure of dogs with avian influenza virus (H5N1). Emerg Infect Dis 2008 Feb;14(2):308-10 [Full text]

* Gilbert M, Chaitaweesub P, Parakamawongsa T, et al. Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg Infect Dis 2006 Feb;12(2) [Full text]

* Gilbert M, Xiao X, Domenech J, et al. Anatidae migration in the western Palearctic and spread of highly pathogenic avian influenza H5N1 virus. Emerg Infect Dis 2006;12(11) (published online Oct 19) [Full text]

* Gilbert M, Xiao X, Pfeiffer DU, et al. Mapping H5N1 highly pathogenic avian influenza risk in Southeast Asia. Proc Natl Acad Sci 2008 (published online Mar 24) [Full text]

* Gill JS, Webby R, Gilchrist MJ, et al. Avian influenza among waterfowl hunters and wildlife professionals. Emerg Infect Dis 2006 Aug;12(8) [Full text]

* Gillim-Ross L, Santos C, Chen Z, et al. Avian influenza H6 viruses productively infect and cause illness in mice and ferrets. J Virol 2008 Nov;82(21):10854-63 [Abstract]

* Gillim-Ross L, Subbarao K. Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses (Perspectives). PLoS Med 2007 Feb;4(2):e91 [Full text]

* Gilsdorf A, Boxall N, Gasimov B, et al. Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. Eurosurveillance Monthly 2006 May;11(5) [Full text]

* Gioia C, Castilletti C, Tempestilli M, et al. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis 2008 Jan;14(1):121-8 (published online Dec 21) [Full text]

* Giriputro S, Agus R, Sulastri S, et al. Clinical and epidemiological features of patients with confirmed avian influenza presenting to Sulianti Saroso Infectious Diseases Hospital, Indonesia, 2005-2007. Ann Acad Med Singapore 2008 Jun;37(6):454-7 [Full text]

* Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18(1):64-76

* Goji NA, Nolan C, Hill H, et al. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis 2008 (published online Jun 24) [Abstract]

* Govorkova EA, Ilyushina NA, Boltz DA, et al. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother 2007 Apr;51(4);1414-24 [Abstract]

* Govorkova EA, Rehg JE, Krauss S, et al. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 2005 Feb;79(4):2191-8 [Abstract]

* Govorkova EA, Webby RJ, Humberd J, et al. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 2006 Jul 15;194(2):159-67 [Full text - See also Hampson below]

* Gray GC, Baker WS. The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther 2007 Dec;82(6):638-41 [Abstract]

* Gray GC, McCarthy T, Capuano AW, et al. Evidence for avian influenza A infections among Iowa's agricultural workers. Influenza Other Resp Viruses 2008 Mar;2(2):61-9 (published online Apr 7) [Abstract]

* Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis 2008 Apr (published online Mar 5) [Full text]

* Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007 Sep 29;370(9593):1137-45 [Full text]

* Guan Y, Chen H, Li KS, et al. A model to control the epidemic of H5N1 influenza at the source. BMC Infect Dis 2007;7:132 (published online Nov 13) [Abstract]

* Guan Y, Shortridge KF, Krauss S, et al. Emergence of avian H1N1 influenza viruses in pigs in China. J Virol 1996 Nov;70(11):8041-6 [Full text]

* Guralnik M, Rosenbloom RA, Petteruti MP, et al. Limitations of current prophylaxis against influenza virus infection. Am J Ther 2007 Sep-Oct;14(5):449-54 [Abstract]

* Gyarmati P, Conze T, Zohari S, et al. Simultaneous genotyping of all hemagglutinin and neuraminidase subtypes of avian influenza viruses by use of padlock probes. J Clin Microbiol 2008 May;46(5):1747-51 [Abstract]

* Hadzhiolova T, Pavlova S, Kotseva R. Laboratory investigation of the first suspected human cases of infection with avian influenza A(H5N1) virus in Bulgaria. Eurosurveillance 2008 Jul 24;13(30):pii=18938 [Full text]

* Hall IM, Gani R, Hughes HE, et al. Real-time epidemic forecasting for pandemic influenza. Epidemiol Infect 2006, published online Aug 24 [Abstract]

* Hall JS, Bentler KT, Landolt G, et al. Influenza infection in wild raccoons. Emerg Infect Dis 2008 Dec;14(12) (published online Oct 31) [Full text]

* Hampson AW, Mackenzie JS. The influenza viruses. Med J Aust 2006 Nov 20;185(10 suppl):S39-43 [Full text]

* Hampson AW. Ferrets and the challenges of H5N1 vaccine formulation. (Commentary) J Infect Dis 2006 Jul 15;194(2):143-5 [Full text - See also Govorkova above]

* Hanson BJ, Boon AC, Lim AP, et al. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respiratory Res 2006;7:126 (published online Oct 14) [Full text]

* Hatta M, Hatta Y, Kim JH, et al. Growth of H5N1 influenza A viruses in the upper respiratory tract of mice. PLoS Pathog 2007 Oct 5;3(10):e133 [Full text]

* Hayden F, Croisier A. Transmission of avian influenza viruses to and between humans. (Commentary) J Infect Dis 2005 Oct 15;192(8):1311-4 [Full text - See also Puzelli below]

* Hayden FG, Cote KM, Douglas RG Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 1980 May;17(5):865-70 [Full text]

* Hayden FG, Palese P. Influenza virus. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology. Ed. 2. Washington, DC: ASM Press, 2002

* Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S119-26 [Abstract]

* Hayman A, Comely S, Lackenby A, et al. NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J Virol 2007 Mar;81(5):2318-27 [Abstract]

* Haynes JR, Dokken L, Wiley JA, et al. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 2009 Jan 22;27(4):530-41 [Abstract]

* He G, Qiao J, Dong C, et al. Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China. Antiviral Res 2008 Jan;77(1):72-6 [Abstract]

* He Q, Velumani S, Du Q, et al. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin Vaccine Immunol 2007 May;14(5):617-23 [Abstract]

* He X, Zhou J, Bartlam M, et al. Crystal structure of the polymerase PAC-PB1N complex from an avian influenza H5N1 virus. Nature 2008 (published online Jul 9) [Abstract]

* Health Canada. Avian influenza: British Columbia (update). Infectious Diseases News Briefs. Apr 8, 2004 [Full text]

* Heiny AT, Miotto O, Srinivasan KN, et al. Evolutionarily conserved protein sequences of influenza A viruses, avian and human, as vaccine targets. PLoS ONE 2007 Nov 21;2(11):e1190 [Full text]

* Henning J, Pfeiffer DU, Vu LT. Risk factors and characteristics of H5N1 highly pathogenic avian influenza (HPAI) post-vaccination outbreaks. Vet Res 2008 Dec 12;40(3):15 [Abstract]

* Herrmann B, Larsson C, Zweygberg BW. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J Clin Microbiol 2001 Jan;39(1):134-8 [Full text]

* HHS. Pandemic influenza plan. Released Nov 2, 2005 [Links to overview and full text]

* Hickman D, Hossain MJ, Song H, et al. An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. J Gen Virol 2008 Nov;89(11):2682-90 [Full text]

* Hien ND, Ha NH, Van NT, et al. Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005. Emerg Infect Dis 2009 Jan (published online Dec 3) [Full text]

* Hien TT, Liem NT, Dung NT, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004 Mar 18;350(12):1179-88 [Full text]

* Higgs ES, Hayden FG, Chotpitayasunondh T, et al. The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. Antiviral Res 2008 Apr;78(1):64-68 [Abstract]

* Hill AW, Guralnick RP, Wilson MJC, et al. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infect Genet Evol 2008 (published online Oct 30) [Abstract]

* Hinjoy S, Puthavathana P, Laosiritaworn Y, et al. Low frequency of infection with avian influenza virus (H5N1) among poultry farmers, Thailand, 2004. Emerg Infect Dis 2008 Mar;14(3):499-501 [Full text]

* Hoelscher MA, Garg S, Bangari DS, et al. Development of adenoviral-vector-based pandemic influenza vaccine against antigenetically distinct human H5N1 strains in mice. Lancet 2006 (published online Feb 2) [Abstract]

* Hoelscher MA, Singh N, Garg S, et al. A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J Infect Dis 2008 (published online Mar 18) [Abstract]

* Hoffmann B, Harder T, Starick E, et al. Rapid and highly sensitive pathotyping of avian influenza A H5N1 virus by using real-time reverse transcription-PCR. J Clin Microbiol 2007 Feb;45(2):600-3 [Abstract]

* Holman DH, Wang D, Raja NU, et al. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine 2008 May 19;26(21):2627-39 [Abstract]

* Horimoto T, Murakami S, Muramoto Y, et al. Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 2007 Sep 15;366(1):23-7 [Abstract]

* Horthongkham N, Srihtrakul T, Athipanyasilp N, et al. Specific antibody response of mice after immunization with COS-7 cell derived avian influenza virus (H5N1) recombinant proteins. J Immune Based Ther Vaccines 2007 Oct;5(1):10 (published online Oct 3) [Abstract]

* Hoschler K, Gopal R, Andres N, et al. Cross-neutralization of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains. Influenza Other Resp Viruses 2007 Sep/Nov;1(5-6):199-206 [Full text]

* Hossain MJ, Hickman D, Perez DR. Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens. PLoS ONE 2008 Sep 9;3(9):e3170 [Full text]

* Hourfar MK, Themann A, Eickmann M, et al. Blood screening for influenza. Emerg Infect Dis 2007 Jul;13(7):1081-3 [Full text]

* Hsu JL, Liu KE, Huang MH, et al. Consumer knowledge and risk perceptions of avian influenza. Poult Sci 2008 Aug;87(8):1526-34 [Abstract]

* Hu AY, Weng TC, Tseng YF, et al. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Vaccine 2008 (published online Aug 28) [Abstract]

* Huai Y, Xiang N, Zhou L, et al. Incubation period for human cases of avian influenza A (H5N1) infection, China. (Letter) Emerg Infect Dis 2008 Nov;14(11):1819-20 [Full text]

* Hulse-Post DJ, Franks J, Boyd K, et al. Molecular changes in the polymerase genes (PA and PB1) associated with high pathogenicity of H5N1 influenza virus in mallard ducks. J Virol 2007 Aug;81(16):8515-24 [Abstract]

* Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci 2005 Jul 26;102(30) [Abstract]

* Humberd J, Boyd K, Webster RG. Emergence of influenza A virus variants after prolonged shedding from pheasants. J Virol 2007 Apr;81(8):4044-51 [Abstract]

* Hurtado TR. Human influenza A (H5N1): a brief review and recommendations for travelers. Wilderness Environ Med 2006 Dec;17(4):276-81 [Abstract]

* IAFP (International Association for Food Protection). Perspectives on avian influenza risk management for food safety professionals. Nov 21, 2005 [Full text]

* Ichinohe T, Tamura SI, Kawaguchi A, et al. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 2007 Nov 1;196(9):1313-20 [Abstract]

* Ilyushina NA, Govorkova EA, Gray TE, et al. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 viruses. PLos Pathog 2008 Apr 11;4(4):e1000043 [Full text]

* Ilyushina NA, Govorkova EA, Russell CJ, et al. Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol 2007 Apr;88(4):1266-74 [Abstract]

* Ilyushina NA, Hay A, Yilmaz N, et al. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother 2008 Nov;52(11):3889-97 [Abstract]

* Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and toll-like receptor 4 signalling as a key pathway of acute lung injury. Cell 2008 Apr 18;133(2):235-49 [Abstract]

* India Press Information Bureau. A vison and road map. Document released at the close of 3-day international conference on avian flu. Dec 6, 2007 [Full text]

* Influenza Team, ECDC. Highly pathogenic avian influenza A/H5N1 in birds within the EU--implications for public health. Eurosurveillance Weekly Jul 5;12(7):E070705.2 [Full text]

* Influenza team, ECDC. Low pathogenicity avian influenzas and human health. Eurosurveillance Weekly 2007 May 31;12(5):E070531.3 [Full text]

* Influenza team, ECDPC. Outbreaks of highly pathogenic avian influenza (A/H5N1) in commercial poultry in Hungary and the UK--public health implications? Eurosurveillance Weekly 2007 Feb 15;12(2):E070215.3 [Full text]

* Inoue K. Highly pathogenic avian flu, Japan. (Letter) Emerg Infect Dis 2004 Jul;10(7):1327-8 [Full text]

* Ip HS, Flint PL, Franson JC, et al. Prevalence of influenza A viruses in wild migratory birds in Alaska: patterns of variation in detection at a crossroads of intercontinental flyways. Virol J 2008;5(1):71 (published online Jun 4) [Abstract]

* Isbarn I, Bucknow R, Himmelreich A, et al. Inactivation of avian influenza virus by heat and high hydrostatic pressure. J Food Prot 2007 Mar;70(3):667-73 [Abstract]

* Isoda N, Sakoda Y, Kishida N, et al. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Arch Virol 2008 (published online Jul 24) [Abstract]

* Itoh Y, Ozaki H, Tsuchiya H, et al. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 2008 Jan 24;26(4):562-72 [Abstract]

* Jadhao SJ, Achenbach J, Swayne DE, et al. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. Vaccine 2008 Mar 25;26(14):1742-50 [Abstract]

* James CM, Foong YY, Mansfield JP, et al. Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Vaccine 2007 Aug 1;25(31):5892-901 [Abstract]

* Jayawardena S, Cheung CY, Barr I, et al. Loop-mediated isothermal amplification for influenza A (H5N1) virus. Emerg Infect Dis 2007 Jun;13(6):899-901 [Full text]

* Jennings LC, Monto AS, Chan PKS, et al. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet Infect Dis 2008 Oct;8(10):650-8 [Abstract]

* Jia B, Shi J, Li Y, et al. Pathogenicity of Chinese H5N1 highly pathogenic avian influenza viruses in pigeons. Arch Virol 2008 (published online Sep 9) [Abstract]

* Jiao P, Tian G, Li Y, et al. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 2008 Feb;82(3):1146-54 [Abstract]

* Jin R, Lv Z, Chen Q, et al. Influenza vaccine based on baculovirus surface display system of Bombyx mori. PLoS ONE Dec 12;2(12):e3933 [Full text]

* Joannis TM, Meseko CA, Okadokun AT, et al. Serologic and virologic surveillance of avian influenza in Nigeria, 2006-7. Eurosurveillance 2008 Oct 16;13(42):pii=19007 [Full text]

* Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006 Dec;80(24):11960-7 [Abstract]

* Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006, published online Sep 27 [Abstract]

* Joseph T, McAuliffe J, Lu B, et al. Evaluation of replication and pathogenicity of avian influenza A subtype viruses in a mouse model. J Virol 2007 Oct;81(19):10558-66 [Abstract]

* Jourdain E, Gauthier-Clerc M, Bicout D, et al. Bird migration routes and risk for pathogen dispersion into western Mediterranean wetlands. Emerg Infect Dis 2007 Mar;13(3) (published online Feb 5) [Full text]

* Kalthoff D, Breithaupt A, Teifke JP, et al. Highly pathogenic avian influenza virus (H5N1) in experimentally infected adult mute swans. Emerg Infect Dis 2008 Aug;14(8):1267-70 [Full text]

* Kalthoff D, Hoffmann B, Harder T, et al Experimental infection of cattle with highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2008 Jul (published online May 28) [Full text]

* Kanamori S, Jimba M. Compensation for avian influenza cleanup. (Letter) Emerg Infect Dis 2007 Feb;13(2) (published online Jan 24) [Full text]

* Kandun IN, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 2008 Aug 30;372(9640):744-9 [Abstract]

* Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006 Nov 23;355(21):2186-94 [Full text]

* Karesh WB, cook RA, Gilbert M, et al. Implications of wildlife trade on the movement of avian influenza and other infectious diseases. J Wildl Dis 2007 Jul;43(3 suppl):S55-9 [Abstract]

* Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006 Oct5;443(7111):578-81 [Abstract]

* Kashyap AK, Steel J, Oner AF, et al. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci 2008 (published online Apr 14) [Abstract]

* Kaverin NV, Rudneva IA, Govorkova EA, et al. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 2007 Dec;81(23):12911-7 [Abstract]

* Kaye D, Pringle CR. Avian influenza viruses and their implication for human health. Clin Infect Dis 2005 Jan 1;40(1):108-12 [Full text]

* Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004 Dec;10(12) [Full text]

* Keawcharoen J, van Riel D, van Amerongen G, et al. Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2008 Apr;14(4):600-7 [Full text]

* Kessler N, Ferraris O, Palmer K, et al. Use of the DNA flow-thru chip, a three-dimensional biochip, for typing and subtyping of influenza viruses. J Clin Microbiol. 2004 May;42(5):2173-85 [Full text]

* Khalenkov A, Perk S, Panshin A, et al. Modulation of the severity of highly pathogenic H5N1 influenza in chickens previously inoculated with Israeli H9N2 influenza viruses. Virology 2008 (published online Nov 7) [Abstract]

* Kilpatrick AM, Chmura AA, Gibbons DW, et al. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci 2006 (published online Dec 7) [Abstract]

* Kishida N, Sakoda Y, Shiromoto M, et al. H2N5 influenza virus isolates from terns in Australia: genetic reasssortants between those of the Eurasian and American lineages. Virus Genes 2008 (published online May 3) [Abstract]

* Kiss I, Gyarmati P, Zohari S, et al. Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006. Virol J 2008 Oct 6;5:113 [Abstract]

* Kistner O, Howard MK, Spruth M, et al. Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine 2007 Aug 10;25(32):6028-36 [Abstract]

* Kleinman AM, Bloom BR, Saich A, et al. Avian and pandemic influenza: a biosocial approach. J Infect Dis 2008 Feb 15;197(S1):S1-S3 [Abstract]

* Koehler AV, Pearce JM, Flint PL, et al. Genetic evidence of intercontinental movement of avian influenza in a migratory bird: the northern pintail (Anas acuta). Mol Ecol 2008 Nov;17(21):4754-62 [Abstract]

* Koh GCH, Yee WT, Kwing CS, et al. Avian influenza: a global threat needing a global solution. (Commentary) Asia Pacific Fam Med 2008 Nov 13;7:5 [Abstract]

* Komar N, Olsen B. Avian influenza virus (H5N1) mortality surveillance. (Letter) Emerg Infect Dis 2008 Jul;14(7):1176-7 [Full text]

* Kongchanagul A, Suptawiwat O, Kanrai P, et al. Positive selection at the receptor-binding site of haemagglutinin H5 in viral sequences derived from human tissues. J Gen Virol 2008 Aug;89(8):1805-10 [Full text]

* Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004 Feb 21;363(9409):587-93 [Abstract]

* Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004 Feb 21;363(9409):587-93 [Abstract]

* Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 2008 (published online Apr 10) [Full text]

* Kotwal GJ. Genetic diversity-independent neutralization of pandemic viruses (eg, HIV), potentially pandemic (eg, H5N1 strain of influenza) and carcinogenic (eg, HBV and HCV) viruses, and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs). Vaccine 2008 Jun 6;26(24):3055-8 [Abstract]

* Kou Z, Lei FM, Yu J, et al. New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. J Virol 2005 Dec;79(24):15460-6 [Abstract]

* Krauss S, Obert CA, Franks J, et al. Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog 2007 Nov 9;3(11):e167 [Full text]

* Kreijtz JH, de Mutsert G, van Baalen CA, et al. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 2008 Jun;82(11):5161-66 [Abstract]

* Kreijtz JH, Osterhaus AS, Rimmelzwaan GF. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza. Hum Vaccines 2009 Mar;5(3) (published online Oct 30) [Abstract]

* Kreijtz JH, Suezer Y, de Mutsert G, et al. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques. J Infect Dis 2008 (published online Dec 5) [Abstract]

* Kreijtz JH, Suezer Y, van Amerongen G, et al. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1. J Infect Dis 2007 Jun 1;195(11):1598-606 [Abstract]

* Kuiken T, Fouchier R, Rimmelzwaan G, et al. Feline friend or potential foe? Nature 2006 Apr 6;440:741-2 [Full text]

* Kuiken T, Holmes EC, McCauley J, et al. Host species barriers to influenza virus infections. (Perspective) Science 2006 Apr 21;312(5772):394-7 [Full text]

* Kuiken T, Rimmelzwaan G, van Riel D, et al. Avian H5N1 influenza in cats. Science 2004 (published online Sep 2) [Abstract - Access requires free registration]

* Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008 Sep 12;26(suppl 4):D59-66 [Full text]

* Kung NY, Morris RS, Perkins NR, et al. Risk for infection with highly pathogenic influenza A virus (H5N1) in chickens, Hong Kong, 2002. Emerg Infect Dis 2007 Mar;13(3) (published online Feb 9) [Full text]

* Lackenby A, Thompson CI, Democratis J. The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 2008 Dec;21(6):626-38 [Abstract]

* Laddy DJ, Yan J, Corbitt N, et al. Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine 2007 Apr 20;25(16):2984-9 [Abstract]

* Laddy DJ, Yan J, Kutzler M, et al. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS ONE 2008 Jun 25;3(6):e2517 [Full text]

* Lalor PA, Webby RJ, Morrow J, et al. Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. J Infect Dis 2008 Jun 15;197(12):1643-52 [Abstract]

* Lam PY. Avian influenza and pandemic influenza preparedness in Hong Kong. Ann Acad Med Singapore 2008 Jun;37(6):489-96 [Full text]

* Lam TTY, Hon CC, Pybus OG, et al. Evolutionary and transmission dynamics of reassortant H5N1 influenza virus in Indonesia. PLoS Pathog 2008 Aug 22;4(8):e1000130 [Full text]

* Lam WY, Tang JW, Yeung ACM, et al. Avian influenza virus A/HK/483/97(H5N1) NS1 protein induces apoptosis in human airway epithelial cells. J Virol 2008 Mar;82(6):2741-51 [Abstract]

* Lancet Editorial Staff. Asian H5N1 still going strong at 10 years old (Leading Edge). Lancet Infect Dis 2007 Mar;7(3):175 [Full text -- Free registration required]

* Landon MR, Amaro RE, Baron R, et al. Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. Chem Biol Drug Des 2008 (published online Jan 17) [Abstract]

* Lang AS, Kelly A, Runstadler JA. Prevalence and diversity of avian influenza viruses in environmental reservoirs. J Gen Virol 2008 Feb;89(2):509-19 [Abstract]

* Latorre-Margalef N, Gunnarsson G, Munster VJ, et al. Effects of influenza A virus infection on migrating mallard ducks. Proc R Soc B 2008 (published online Dec 2) [Abstract]

* Lau EHY, Leung YHC, Zhang LJ, et al. Effect of interventions on influenza A (H9N2) isolation in Hong Kong's live poultry markets, 1999-2005. Emerg Infect Dis 2007 Sep;13(9):1340-7 [Full text]

* Lau JT, Kim JH, Tsui HY, et al. Perceptions related to bird-to-human avian inlfuenza, influenza vaccination, and use of face mask. Infection 2008 (published online Sep 15) [Abstract]

* Le MTQ, Wertheim HFL, Nguyen HD, et al. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS ONE 2008 Oct 6;3(10):e3339 [Full text]

* Le QM, Kiso M, Someya K, et al. Isolation of drug-resistant H5N1 virus. Nature 2005 Oct 20;437:1108 [Abstract]

* Leask J, Chapman S, Hawe P, et al. What maintains parental support for vaccination when challenged by anti-vaccination messages? A qualitative study. Vaccine 2006 Nov 30;4(49-50):7238-45 [Abstract]

* Lee CW, Suarez DL, Tumpey TM, et al. Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea. J Virol 2005 Mar;79(6):3692-702 [Full text]

* Lee J, Song YJ, Park JH, et al. Emergence of amantadine-resistant H3N2 avian influenza A virus in South Korea. J Clin Microbiol 2008 Nov;46(11):3788-90 [Abstract]

* Lee JS, Kim HS, Seo SH. Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine. Vaccine 2008 Dec 2;26(51):6569-76 [Abstract]

* Lee LHW, Ha DLA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008 (published online Sep 18) [Full text]

* Lee SMY, Cheung CY, Nicholls JM, et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 2008 Aug 15;198(4):525-35 [Abstract]

* Lee YJ, Choi YK, Kim YJ, et al. Highly pathogenic avian influenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea. Emerg Infect Dis 2008 Mar;14(3):487-90 [Full text]

* Legastelois I, Garcia-Sastre A, Palese P, et al. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza Other Respir Virus 2007 (published online Jul 26) [Full text]

* Leroux-Roels I, Bernhard R, Gerard P, et al. Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. PLoS ONE 2008 Feb 27;3(2):e1665 [Full text]

* Leroux-Roels K, Borkowski A, Vanwolleghem T, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007 Aug 18;370(9587):580-9 [Abstract - Free registration required]

* Leschnik M, Weikel J, Mosti K, et al. Subclinical infection with avian influenza A (H5N1) virus in cats. Emerg Infect Dis 2007 Feb;13(2):243-7 [Full text]

* Leschnik M, Weikel J, Mostl K, et al. Subclinical infection with avian influenza A H5N1 virus in cats. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 17) [Full text]

* Leslie T, Billaud J, Mofleh J, et al. Knowledge, attitudes, and practices regarding avian influenza (H5N1), Afghanistan. Emerg Infect Dis 2008 Sep;14(9) (published online Aug 9) [Full text]

* Leung YHC, Zhang LJ, Chow CK, et al. Poultry drinking water used for avian influenza surveillance. Emerg Infect Dis 2007 Sep;13(9):1380-2 [Full text]

* Levie K, Leroux-Roels I, Hoppenbrouwers K, et al. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults. J Infect Dis 2008 (published online Jun 24) [Abstract]

* Li C, Ping J, Jing B, et al. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens. Biochem Biophys Res Comm 2008 (published online May 22) [Abstract]

* Li FCK, Choi BCK, Pak AWP. Finding the real case-fatality rate of H5N1 avian influenza. J Epidemiol Comm Health 2008 Jun;62(6):555-9 [Abstract]

* Li J, Cai H, Liu Q, et al. Molecular and pathological characterization of two H5N1 avian influenza viruses isolated from wild ducks. Virus Genes 2008 (published online Jun 3) [Abstract]

* Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004 Jul 8;430:209-13 [Abstract]

* Li KS, Xu KM, Peiris JS, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 2003 Jun;77(12):6988-94 [Full text]

* Li Z, Chen J, Jiao P, et al. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 2005 Sep;79(18):12058-64 [Abstract]

* Li Z, Jiang Y, Jiao P, et al. The NS1 gene contributes to the virulence of H5N1 avian influenza virus. J Virol 2006 Nov;80(22):11115-23 [Abstract]

* Liem NT, WHO International Avian Influenza Investigation Team - Vietnam, Lim W. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 2005 Feb;11(2) [Full text]

* Lierz M, Hafez HM, Klopfleisch R, et al. Protection and virus shedding of falcons vaccinated against highly pathogenic avian influenza A virus (H5N1). Emerg Infect Dis 2007 Nov;13(11):1667-74 [Full text]

* Lim APC, Chan CEZ, Wong SKK, et al. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library. Virol J 2008 Oct 28;5:130 [Abstract]

* Lim APC, Wong SKK, Chan AHY, et al. Epitope characterization of the protective monoclonal antibody VN01-2 shows broadly neutralizing activity against highly pathogenic H5N1. Virology J 2008 Jul 11;5:80 [Abstract]

* Lim WS, Thomson A, Little P. Preparing for the next flu pandemic (Editorial). BMJ 2007 Feb 10;334(7588):268-9 [Abstract]

* Lin J, Zhang J, Dong X, et al. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet 2006 (published online Sep 7) [Abstract - access requires free registration]

* Lin JH, Tseng CP, Chen YJ, et al. Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis. J Clin Microbiol 2008 Mar;46(3):1090-7 [Abstract]

* Lin JT, Li CG, Wang X, et al. Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine. J Infect Dis 2009 Jan 15;199(2):184-7 [Abstract]

* Lindegardh N, Davies GR, Hien TT, et al. Importance of collection tube during clinical studies of oseltamivir. Antimicrob Agents Chemother 2007 May;51(5):1835-6 [Abstract]

* Lipatov AS, Evseenko VA, Yen HL, et al. Influenza (H5N1) viruses in poultry, Russian Federation, 2005-2006. Emerg Infect Dis 2007 Apr 13(4) (published online Mar 15) [Full text]

* Lipatov AS, Govorkova EA, Webby RJ, et al. Influenza: emergence and control. J Virol 2004 Sep;78(17):8951-9 [Full text]

* Lipatov AS, Kwon YK, Sarmento LV, et al. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog 2008 Jul 11;4(7):e1000102 [Full text]

* Lipatov AS, Webby RJ, Govorkova EA, et al. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 2005 Apr 15;191(8):1216-20 [Abstract]

* Liu CM, Lin SH, Chen YC, et al. Temperature drops and the onset of severe avian influenza A H5N1 virus outbreaks. PLoS One 2007 Feb 7;2(2):e191 [Full text]

* Liu J, Xiao H, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 2005 (published online Jul 6) [Abstract]

* Liu J, Xiao J, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. (Brevia) Science 2005 Aug 19;309(5738):1206 [Full text]

* Loth L, Prijono WB, Wibawa H, et al. Evaluation of two avian influenza type A rapid antigen tests under Indonesian field conditions. J Vet Diagn Invest 2008 Sep;20(5):642-4 [Abstract]

* Low DE. Pandemic planning: non-pharmaceutical interventions. Respirology 2008 Mar;13(s1):S44-8 [Full text]

* Lu PS. Early Diagnosis of avian influenza. (Editorial) Science 2006 Apr 21;312(5772):337 [Summary]

* Lucio-Forster A, Bowman DD, Lucio-Martinez B, et al. Inactivation of the avian influenza virus (H5N2) in typical domestic wastewater and drinking water treatment systems. Environ Eng Sci 2006 Nov;23(6):897-903 [Full text]

* Luke TC, Kilbane EM, Jackson JL, et al. Meta-analysis: convalescent blood products for Spanish influenza: a future H5N1 treatment? Ann Intern Med 2006 Oct 17;145(8) (early online publication) [Abstract - See also Treanor editorial below]

* Ly S, Van Kerkhove MD, Holl D, et al. Interaction between humans and poultry, rural Cambodia. Emerg Infect Dis 2007 Jan;13(1) (published online Dec 20) [Full text]

* Ma W, Vincent AL, Gramer MR, et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci 2007 (published online Dec 18) [Abstract]

* Maas R, Tacken M, Ruuls L, et al. Avian influenza (H5N1) susceptibility and receptors in dogs. Emerg Infect Dis 2007 Aug;13(8):1219-21 [Full text]

* Mahmood K, Bright RA, Mytle N, et al. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine 2008 Oct 3;26(42):5393-9 [Abstract]

* Mahmood K, Bright RA, Mytle N, et al. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 viruses. Vaccine 2008 Oct 3;26(42):5393-9 [Abstract]

* Maines TR, Chen LM, Matsuoka Y, et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci 2006 Aug 8;103(32):1221-6 [Abstract]

* Maines TR, Lu XH, Erb SM, et al. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 2005 Sep;79(18):11788-800 [Abstract]

* Maines TR, Szretter K, Perrone L, et al. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 2008 Oct;225(1):68-84 [Abstract]

* Majury A, Ash J, Toye B, et al. Laboratory diagnosis of human infection with avian influenza. CMAJ 2006 Nov 21;175(11):1371-2 [Full text]

* Marangon S, Cecchinato M, Capua I. Use of vaccination in avian influenza control and eradication. Zoonoses Public Health 2008 Feb;55(1):65-72 [Abstract]

* Marcus PI, Girshick T, van der Heide L, et al. Super-sentinel chickens and detection of low-pathogenicity influenza virus. Emerg Infect Dis 2007 Oct;13(10):1608-10 [Full text]

* Marsden-Haug N, Foster VB, Gould PL, et al. Code-based syndromic surveillance for influenzalike illness by International Classification of Diseases, Ninth Revision. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 11) [Full text]

* Martinez M, Perez Am, de la Torre A, et al. Association between number of wild birds sampled for identification of H5N1 avian influenza virus and incidence of the disease in the European Union. Transbound Emerg Dis 2008 (published online Sep 2) [Abstract]

* Mase M, Tanimura N, Imada T, et al. Recent H5N1 avian Influenza A virus increases rapidly in virulence to mice after a single passage in mice. J Gen Virol 2006 Dec;87(12):3655-9 [Abstract]

* Matrosovich M, Matrosovich T, Uhlendorff J, et al. Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology 2007 May 10;361(2):384-90 [Abstract]

* Matrosovich MN, Matrosovich TY, Gray T, et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci 2004 Mar 30;101(13):4620-4 [Full text]

* McKimm-Breschkin J, Trivedi T, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003 Jul;47(7):2264-72 [Full text]

* McKimm-Breschkin JL, Selleck PW, Usman TB, et al. Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg Infect Dis 2007 Sep;13(9):1354-7 [Full text]

* McSwiggen JA, Seth S. A potential treatment for pandemic influenza using siRNA targeting conserved regions of influenza A. Expert Opin Biol Ther 2008 Mar;8(3):299-313 [Abstract]

* Mehle A, Doudna JA. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe 2008 Aug 14;4(2):111-22 [Abstract]

* Mehlmann, M, Bonner AB, Williams JV, et al. Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza. J Clin Microbiol 2007 Apr;45(4):1234-7 [Abstract]

* Meijer A, Du Ry van Beest Holle M, Fouchier R, et al. Human infection associated with outbreak of fowl plague (avian influenza) in the Netherlands: update 27. Eurosurveillance Weekly 2003 Mar 27;7(13) [Full text]

* Melnychuk RM, Kenny NP. Pandemic triage: the ethical challenge (Commentary). CMAJ 2006 Nov 21;74(11):1393-4 [Full text]

* Middleton D, Bingham J, Selleck P, et al. Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virol 2007 Mar;359(1):66-71 [Abstract]

* Mok CK, Lee DC, Cheung CY, et al. Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol 2007 Apr;88(4):1275-80 [Abstract]

* Monne I, Fusaro A, Al-Blowi MH, et al. Co-circulation of two sublineages of HPAI H5N1 virus in the Kingdom of Saudi Arabia with unique molecular signatures suggesting separate introductions into the commercial poultry and falconry sectors. J Gen Virol 2008 Nov;89(11):2691-7 [Full text]

* Monne I, Joannis TM, Fusaro A, et al. Reassortant avian influenza virus (H5N1) in poultry, Nigeria, 2007. Emerg Infect Dis 2008 Apr;14(4):637-40 [Full text]

* Monne I, Ormelli S, Salviato A, et al. Development and validation of a one-step real-time PCR assay for simultaneous detection of subtype H5, H7, and H9 avian influenza viruses. J Clin Microbiol 2008 May;46(5):1769-73 [Abstract]

* Monto AS. The threat of an avian influenza pandemic. (Perspective) N Engl J Med 2005 Jan 27;352(4):323-4 [Full text]

* Morens DM, Folkers GK, Fauci AS. Emerging infections: a perpetual challenge. Lancet Infect Dis 2008 Nov;8(11):710-9 [Abstract]

* Morgan A. Avian influenza: an agricultural perspective. J Infect Dis 2006 Nov 1;194(suppl 2):S139-46 [Abstract]

* Morgan O, Kuhne M, Nair P, et al. Personal protective equipment and risk for avian influenza (H7N3). Emerg Infect Dis 2009 Jan;15(1):59-62 [Full text]

* Morse SS, Garwin RL, Olsiewski PJ. Next flu pandemic: What to do until the vaccine arrives? [Policy Forum]. Science Nov 10;314(5801):929 [Abstract]

* Moscona A. Oseltamivir resistance: disabling our influenza defenses. (Perspective) N Engl J Med 2005 Dec 22;353(24):2633-6 [Full text]

* Mossialos E, Rudisill C. Knowledge about avian influenza, European region. (Letter) Emerg Infect Dis 2008 Dec;14(12):1956 [Full text]

* Munasinghe S, Brown G, Pereira A, et al. Public health response to an avian influenza A (H5N1) poultry outbreak in Suffolk, United Kingdom, in November 2007. Eurosurveillance Weekly Jan 31;13(5) [Full text]

* Munster VJ, Baas C, Lexmond P, et al. Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog 2007 May;3(5):e61 [Full text]

* Munster VJ, de Wit E, van Riel D, et al. The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis 2007 Jul 15;196(2):258-65 [Abstract]

* Munster VJ, Wallensten A, Baas C, et al. Mallards and highly pathogenic avian influenza ancestral viruses, Northern Europe. Emerg Infect Dis 2005 Oct;11(10) [Full text]

* Murakami S, Horimoto T, Yamada S, et al. Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production. J Virol 2008 Feb;82(3):1605-9 [Abstract]

* Murray CJ, Lopez AD, Chin B, et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006 Dec 23;368(9554):2211-8 [Full text]

* Myers KP, Setterquist SF, Capuano AW, et al. Infection due to 3 avian influenza subtypes in United States veterinarians. Clin Infect Dis 2007 Jul 1;45(1):4-9 [Abstract]

* Naksupan N, Sanguansermsri D, Wongvilairat R, et al. Whole genome sequences of H5N1 influenza virus isolated from a little grebe in Thailand. Southeast Asian J Trop Med Publ Health 2008 May;39(3):373-8 [Abstract]

* Nature editorial staff. The long war against flu. (Editorial) Nature 2008 Jul 10;454(7201):137 [Full text]

* Needham H, on behalf of the Influenza Project Team, ECDC. H5N1 in wild and domestic birds in Europe--remaining vigilant in response to an ongoing public threat. Eurosurveillance Weekly 2007 Dec 6;12(12):E017206.1 [Full text]

* Nelson MI, Holmes EC. The evolution of epidemic influenza. Nature Rev Genet 2007 Mar;8(3):196-205 [Abstract]

* Newton DW, Mellen CF, Baxter BD, et al. Practical and sensitive screening strategy for detection of influenza virus. J Clin Microbiol 2002 Nov;40(11):4353-6 [Full text]

* Ng EK, Cheng PK, Ng AY, et al. Influenza A H5N1 detection. Emerg Infect Dis 2005 Aug;11(8) [Full text]

* Ng LFP, Barr I, Nguyen T, et al. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infect Dis 2006;6(40) [Full text]

* Nguyen DC, Uyeki TM, Jadhao S, et al. Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol 2005 Apr;79(7):4201-12 [Abstract]

* Nguyen TD, Nguyen TV, Vijaykrishna D, et al. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg Infect Dis 2008 Apr;14(4):632-6 [Full text]

* NIAID. NIAID announces contracts to develop vaccine against H5N1 avian influenza. May 27, 2004 [Press release]

* NIAID. Timeline of human flu pandemics [Web page]

* Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S111-8 [Abstract]

* Nicholls JM, Bourne AJ, Chen H, et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 2007;8:73 (published online Oct 25) [Abstract]

* Nicholls JM, Chan MC, Chan WY, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Med 2007 Feb;13(2):147-9 [Abstract]

* Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003 Nov 22;362(9397):1733-45 [Abstract]

* Nicoll A. Children, avian influenza H5N1, and preparing for the next pandemic. Arch Dis Childhood 2008 May;93(5):433-8 [Abstract]

* Nicoll A. Human H5N1 infections: so many cases - why so little knowledge? Eurosurveill Monthly 2006 May;11(5) [Full text]

* Nicoll A. Personal (nonpharmaceutical) protective measures for reducing transmission of influenza - ECDC interim recommendations. Eurosurveill Wkly 2006 Oct 12;11(10):E061012.1 [Full text]

* Ninomiya A, Imai M, Tashiro M, et al. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model. Vaccine 2007 May 4;25(18):3554-60 [Abstract]

* NIOSH (National Institute for Occupational Safety and Health). Protecting poultry workers from avian influenza (bird flu). Released Feb 20, 2008 [Full text]

* Nolan TM, Richmond PC, Skekjo MV, et al. Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. Vaccine 2008 Aug 5;26(33):4160-7 [Abstract]

* Nomille D. Flu virus research yields results but no magic bullet for pandemic. (News analysis) Science 2008 Feb 29;319(5687):1178-9 [Full text]

* Obenauer JC, Denson J, Mehta PK, et al. Large-scale sequence analysis of avian influenza isolates. Science 2006 (published online Jan 26) [Abstract]

* Obenauer JC, Denson J, Mehta PK, et al. Large-scale sequence analysis of avian influenza isolates. Science 2006 Mar 17;311(5767):1576-80 [Abstract]

* Ogata T, Yamazaki Y, Okabe N, et al. Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer. J Epidemiol 2008 (published online Jul 7) [Abstract]

* OIE. Highly pathogenic avian influenza. Technical disease card database. Apr 22, 2002 [Webpage]

* OIE. Manual of diagnostic tests and vaccines for terrestrial animals: avian influenza. Chapter 2.3.4. Jul 2008 [Full text]

* OIE/FAO. Susceptibility of animal species to the H5N1 Asian strain. Apr 14, 2006 [Full text]

* Okazaki K, Takada A, Ito T, et al. Precursor genes of future pandemic influenza viruses are perpetuated in ducks nesting in Siberia. Arch Virol 145(5):885-93 [Abstract]

* Olsen B, Munster VJ, Wallensten A, et al. Global patterns of influenza A virus in wild birds. Science 2006 Apr 21;312(5772):384-8 [Full text]

* Olsen CW, Karasin AI, Carman S, et al. Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis 2006 Jul;12(7):1132-5 [Full text]

* Olsen SJ, Laosiritaworn Y, Pattanasin S, et al. Poultry-handling practices during avian influenza outbreak, Thailand. Emerg Infect Dis 2005 Oct;11(10):1601-2 [Full text]

* Olsen SJ, Ungchusak K, Birmingham M, et al. Surveillance for avian influenza in human beings in Thailand. Lancet Infect Dis 2006 Dec;6(12):757-8 [Full text - Free registration required]

* Olsen SJ, Ungchusak K, Sovann L, et al. Family clustering of avian influenza A (H5N1). Emerg Infect Dis 2005 Nov;11(11):1799-801 [Full text]

* Oner AF, Bay A, Arslan S, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006 Nov 23;355(21):2179-85 [Full text]

* Ong A, Kindhauser M, Smith I, et al. A global perspective on avian influenza. Ann Acad Med Singapore 2008 Jun;37(6):477-81 [Full text]

* Ong AK, Hayden FG. John F. Enders lecture 2006: antivirals for influenza. J Infect Dis 2007 Jul 15;196(2):181-90 [Abstract]

* Ortiz JR, Katz MA, Mahmoud MN, et al. Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis 2007 Dec 1;196(11):1685-91 [Full text]

* Ortiz JR, Wallis TR, Katz MA, et al. No evidence of avian influenza A (H5N1) among returning US travelers. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 24) [Full text]

* Osterhaus ADME, Poland GA (eds). Influenza vaccines: research, development and public health challenges. Vaccine 2008 Sep 12;26(suppl 4):D1-174 [Abstract]

* Osterholm MT, Branswell H. Emerging pandemic: costs and consequences of an avian influenza outbreak. Webcast of presentation at Woodrow Wilson International Center for Scholars. Sep 19, 2005 [Web page with links]

* Owen RE, Yamada E, Thompson CI, et al. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J Virol 2007 Oct;81(20):11170-8 [Abstract]

* Owoade AA, Gerloff NA, Ducatez MF, et al. Replacement of sublineages of avian influenza (H5N1) by reassortments, sub-Saharan Africa. Emerg Infect Dis 2008 Nov (published online Oct 1) [Full text]

* Oxford JS, Lambkin R, Guralnik M, et al. In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection. Am J Ther 2007 Sep-Oct;14(5):462-8 [Abstract]

* Oxford JS, Lambkin R, Guralnik M, et al. Preclinical in vitro activity of QR-435 against influenza A virus as a virucide and in paper masks for prevention of viral transmission. Am J Ther 2007 Sep-Oct;14(5):455-61 [Abstract]

* Pachucki CT, Khurshid MA, Nawrocki J. Utility of reverse transcriptase PCR for rapid diagnosis of influenza a virus infection and detection of amantadine-resistant influenza a virus isolates. J Clin Microbiol. 2004 Jun;42(6):2796-8 [Full text]

* Paltrinieri S, Spagnolo V, Giordano A, et al. Influenza virus type A serosurvey in cats. (Letter) Emerg Infect Dis 2007 Apr;13(4) (published online Feb 28) [Full text]

* Pandemic Flu May 26 issue of Nature featuring a collection of commentaries and other articles on pandemic and avian influenza [Links to full text]

* Pantin-Jackwood MJ, Suarez DL, Spackman E, et al. Age at infection affects the pathogenicity of Asian highly pathogenic avian influenza H5N1 viruses in ducks. Virus Res 2007 Dec;130(1-2):151-61 [Abstract]

* Pappas C, Matsuoka Y, Swayne DE, et al. Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness. Clin Vaccine Immunol 2007 Nov;14(11):1425-32 [Abstract]

* Park AW, Glass K. Dynamic patterns of avian and human influenza in east and southeast Asia. Lancet Infect Dis 2007 Aug;7(8):543-8 [Abstract]

* Park MS, Steel J, Garcia-Sastre A, et al. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci 2006 May 23;103(21):8203-8 [Abstract]

* Parker D, Alcorn M, Johnston A. Outbreak of highly pathogenic avian influenza in The Netherlands. Vet Rec 2003 Mar 15;152(11):338

* Parmley EJ, Bastien N, Booth TF, et al. Wild bird influenza survey, Canada, 2005. Emerg Infect Dis 2008 Jan;14(1):84-7 [Full text]

* Pasick J, Berhane Y, Embury-Hyatt C, et al. Susceptibility of Canada geese (Branta canadensis) to highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2007 Dec;13(12):1821-7 (published online Nov 5) [Full text]

* Patnayak DP, Prasad AM, Malik YS, et al. Efficacy of disinfectants and hand sanitizers against avian respiratory viruses. Avian Dis 2008 Jun;52(2):199-202 [Abstract]

* Pawitan JA. Averting avian influenza pandemic: SOS from a developing country. Lancet Infect Dis 2006;6(12):756-7 [Full text - Free registration required]

* Payungporn S, Chuinimitkul S, Chaisingh A, et al. Discrimination between highly pathogenic and low pathogenic H5 avian influenza A viruses. (Letter) Emerg Infect Dis 2006 April;12(4) [Full text]

* Payungporn S, Chutinimitkul S, Chaisingh A, et al. Single step multiplex real-time RT-PCR for H5N1 influenza A virus detection. J Virol Methods. 2005 Sep 22. [Abstract, E-publication ahead of print]

* Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007 Apr;20(2):243-67 [Abstract]

* Peiris JS, Guan Y, Markwell D, et al. Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol 2001 Oct;75(20):9679-86 [Full text]

* Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet 1999;354:916-7 [Abstract]

* Peltz R, Avisar-Shohat G, Bar-Dayan Y. Differences in public emotions, interest, sense of knowledge and compliance between the affected area and the nationwide general population during the first phase of a bird flu outbreak in Israel. J Infect 2007 Dec;55(6):545-50 [Abstract]

* Peng F, Wang Z, Zhang S, et al. Development of an immunochromatographic strip for rapid detection of H9 subtype avian influenza viruses. Clin Vaccine Immunol 2008 Mar;15(3):569-74 [Abstract]

* Perdue ML. Molecular diagnostics in an insecure world. Avian Dis 2003;47(3 Suppl):1063-8 [Abstract]

* Pereda AJ, Uhart M, Perez AA, et al. Avian influenza virus isolated in waterfowl in Argentina: evidence of a potentially unique phylogenetic lineage in South America. Virology 2008 Sep 1;378(2):363-78 [Abstract]

* Perez DR, Webby RJ, Hoffmann E, et al. Land-based birds as potential disseminators of avian mammalian reassortant influenza A viruses. Avian Dis 2003;47(3 Suppl):1114-7 [Abstract]

* Perrone LA, Plowden JK, Garcia-Sastre A, et al. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008 Aug 1;4(8):e1000115 [Full text]

* Peterson AT, Benz BW, Papes M. Highly pathogenic H5N1 avian influenza: entry pathways into North America via bird migration. PLoS One 2007 Feb 28;2(2):e261 [Full text]

* Peterson AT, Bush SE, Spackman E, et al. Influenza A virus infections in land birds, People's Republic of China. Emerg Infect Dis 2008 Oct (published online Aug 29) [Full text]

* Peyre M, Fusheng G, Desvaux S, et al. Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience. Epidemiol Infect 2008 (published online Aug 14) [Abstract]

* Philippa J, Baas C, Beyer W, et al. Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine. Vaccine 2007 May 10;25(19):3800-8 [Abstract]

* PHS (Poultry Health Services). Fowl plague, avian influenza highly pathogenic. PHS Avian Influenza Forum [Webpage]

* Pipper J, Inoue M, Ng LFP, et al. Catching bird flu in a droplet. Nature Med 2007 Oct 13;13(10):1259-63 [Abstract]

* Pitzer VE, Olsen SJ, Bergstrom CT, et al. Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg Infect Dis 2007 Jul;13(7):1074-6 [Full text]

* Poland GA, Jacobson RM, Targonski PV. Avian and pandemic influenza: An overview. Vaccine 2007 Apr 20;25(16):3057-61 [Abstract]

* Poland GA. Vaccines against avian influenza--a race against time. (Editorial) N Engl J Med 2006 Mar 30;354(13):1411-13 [Full text]

* Polgreen PM, Nelson FD, Neumann GR. Use of prediction markets to forecast infectious disease activity. Clin Infect Dis 2007 Jan 15;44(2):272-9 [Abstract]

* Pourmand N, Diamond L, Garten R, et al. Rapid and highly informative diagnostic assay for H5N1 influenza viruses. PLoS One 2006 Dec 20;1(1):e95 [Full text]

* Prabakaran M, Velumani S, He F, et al. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology 2008 Oct 25;380(2):412-20 [Abstract]

* Pushko P, Tumpey TM, Van Hoeven N, et al. Evaluation of influenza-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine 2007 May 22;25(21):4283-90 [Abstract]

* Puthavathana P, Sangsiriwut K, Korkusol A, et al. Avian influenza virus (H5N1) in human, Laos. (Letter) Emerg Infect Dis 2009 Jan;15(1):127-9 [Full text]

* Puzelli S, De Trani L, Fabiani C, et al. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2004. J Infect Dis 2005 Oct 15;192(8):1318-22 [Full text - See also Hayden above]

* Quan FS, Huang C, Compans RW, et al. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 2007 Apr;81(7):3514-24 [Abstract]

* Quoilin S, Thomas I, Gerard C, et al. Management of potential human cases of influenza A/H5N1: lessons from Belgium. Eurosurveillance Weekly 2006 Jan 29;11(1) [Full text]

* Rabadan R, Levine AJ, Robins H. Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes. J Virol 2006 Dec;80(23):11887-91 [Abstract]

* Rameix-Welti MA, Agou F, Buchy P, et al. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob Agents Chemother 2006 Nov;50(11):3809-15 [Abstract]

* Ramirez A, Capuano AW, Wellman DA, et al. Preventing zoonotic influenza virus infection. Emerg Infect Dis 2006 Jun;12(6):997-1000 [Full text]

* Rappole JH, Hubalek Z. Birds and influenza H5N1 virus movement to and within North America. (Perspective) Emerg Infect Dis 2006;12(10):1486-92 [Full text]

* Raviv Y, Blumenthal R, Tompkins SM, et al. Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity. J Virol 2008 May;82(9):4612-9 [Abstract]

* Ray K, Potdar VA, Cherian SS, et al. Characterization of the complete genome of influenza A (H5N1) virus isolated during the 2006 outbreak of poultry in India. Virus Genes 2008 (published online Jan 24) [Abstract]

* Reperant LA, van Amerongen G, van de Bildt MWG, et al. Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses. Emerg Infect Dis 2008 Dec;14(12) (published online Oct 31) [Full text]

* Rice EW, Adcock NJ, Sivaganesan M, et al. Chlorine inactivation of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2007 Oct;13(10):1568-70 [Full text]

* Rigoni M, Shinya K, Toffan A, et al. Pneumo- and neurotropism of avian origin Italian highly pathogenic avian influenza H7N1 isolates in experimentally infected mice. Virology 2007 Jul 20;364(1):28-35 [Abstract]

* Rimmelzwaan GF, McElhaney JE. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008 Sep 12;26(suppl 4):D41-44 [Full text]

* Rimmelzwaan GF, van Riel D, Baars M, et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006 Jan;168(1):176-83 [Abstract]

* Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999 Apr;37(4):937-43 [Full text]

* Roy S, Kobinger GP, Lin J, et al. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 2007 Sep 28;25(39-40):6845-51 [Abstract]

* Ruat C, Caillet C, Bidaut A, et al. Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 without disease enhancement. J Virol 2008 Mar;82(5):2565-9 [Abstract]

* Rumke HC, Bayas JM, de Juanes JR, et al. Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial. Vaccine 2008 May 2;26(19):2378-88 [Abstract]

* Russell RJ, Haire LF, Stevens DJ, et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006 Sep 7;443(7107):45-9 [Abstract]

* Saad MD, Ahmed LS, Gamal-Eldein MA, et al. Possible avian influenza (H5N1) from migratory bird, Egypt. (Letter) Emerg Infect Dis 2007 Jul;13(7):1120-1 [Full text]

* Safdar A, Rodriguez MA, Fayad LE, et al. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma. J Infect Dis 2006 Nov 15;194(10):1394-97 [Abstract]

* Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci 2007 (published online Jul 17) [Abstract]

* Salzberg S. The contents of the syringe. (Commentary) Nature 2008 Jul 10;454(7201):160-1 [Full text]

* Salzberg SL, Kingsford C, Cattoli G, et al. Genome analysis linking recent European and African influenza (H5N1) viruses. Emerg Infect Dis 2007 May;13(5) (published online Apr 4) [Full text]

* Samaan G, Patel M, Olowokure B, et al. Rumor surveillance and avian influenza H5N1. Emerg Infect Dis 2005 Mar;11(3):463-6 [Full text]

* Sampath R, Russell KL, Massire C, et al. Global surveillance of emerging influenza virus genotypes by mass spectrometry. PLoS One 2007 May 30;2(5):e489 [Full text]

* Sandbulte MR, Jimenez GS, Boon AC, et al. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007 Feb 13;4(2):e59 [Full text]

* Sandman PM, Lanard J. Bird flu: communicating the risk. Perspect Health 2005;19(2) [Full text]

* Sandrock C, Kelly T. Clinical review: update of avian influenza A infections in humans. Crit Care 2007 Mar 22;11(2):209 [Full text]

* Sarikaya O, Erbaydar T. Avian influenza outbreak in Turkey through health personnel's views: a qualitative study. BMC Public Health 2007;7(1):330 (published online Nov 15) [Abstract]

* Savill NJ, St Rose SG, Woolhouse MEJ. Detection of mortality clusters associated with highly pathogenic avian influenza in poultry: a theoretical analysis. J R Soc Interface 2008 (published online May 13) [Abstract]

* Sawai T, Itoh Y, Ozaki H, et al. Induction of cytotoxic T-lymphocytes and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin. Immunology 2008 (published online Jan 16) [Abstract]

* Schultsz C, Dong VC, Chau NVV, et al. Avian influenza H5N1 and healthcare workers. (Letter) Emerg Infect Dis 2005 Jul;11(7) [Full text]

* Schultz-Cherry S, McCukllers JA. A step closer to meeting the threat of avian influenza. PLoS Med 2006 Sep;3(9) [Full text]

* Schunemann HJ, Hill SR, Kakad M, et al. Transparent development of the WHO Rapid Advice Guidelines. PLoS Med 2007 May;4(5):e119 [Full text]

* Schunemann HJ, Hill SR, Kakad M, et al. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 2007 Jan;7(1):21-31 [Abstract]

* Schwartz JAl, Buonocore L, Roberts A, et al. Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. Virology 2007 Sep 15;366(1):166-73 [Abstract]

* Scoones I, Forster P. The international response to highly pathogenic avian influenza: science, policy and politics. (STEPS Centre report) Released Oct 23, 2008 [Full text]

* Security and Prosperity Partnership of North America. North American plan for avian & pandemic influenza. Released Aug 21, 2007 [Full text]

* Sedyaningsih ER, Isfandari S, Setiawaty V, et al. Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. J Infect Dis 2007 Aug 15;196(4):522-7 [Abstract]

* Sengupta R, Rosenshein L, Gilbert M, et al. Ecoregional dominance in spatial distribution of avian influenza (H5N1) outbreaks. (Letter) Emerg Infect Dis 2007 Aug;13(8):1269-70 [Full text]

* Senne DA, Suarez DL, Stallnecht DE, et al. Ecology and epidemiology of avian influenza in North and South America. In Proceedings of OIE/FAO International Scientific Conference on Avian Influenza, Paris, Apr 2005. Dev Biol (Basel). 2006;124:37-44 [Abstract]

* Shan S, Ko LS, Collins RA, et al. Comparison of nucleic acid-based detection of avian influenza H5N1 with virus isolation. Biochem Biophys Res Commun 2003 Mar 7;302(2):377-83 [Abstract]

* Sharkey KJ, Bowers RG, Morgan KL, et al. Epidemiological consequences of an incursion of highly pathogenic H5N1 avian influenza into the British poultry flock. Proc R Soc B 2007 (published online Oct 25) [Abstract]

* Sharpe M, Lynch D, Topham S, et al. Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. Vaccine 2007 Aug 21;25(34):6392-8 [Abstract]

* Shestopalov AM, Durimanov AG, Evseenko VA, et al. H5N1 influenza virus, domestic birds, Western Siberia, Russia. (Letter) Emerg Infect Dis 2006 Jul;12(7) [Full text]

* Shi D, Yang J, Yang D, et al. Anti-influenza viral prodrug oseltamivir is activated by carboxylesterase HCE1 and the activation is inhibited by anti-platelet agent clopidogrel. J Pharmacol Exp Ther 2006 (published online Sep 11) [Abstract]

* Shi H, Liu XF, Zhang X, et al. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Vaccine 2007 Oct 16;25(42):7379-84 [Abstract]

* Shinya K, Ebina M, Yamada S, et al. Avian flu: influenza virus receptors in the human airway. (Brief Report) Nature 2006 Mar 23;440(7083):435-6 [Full text]

* Shinya K, Hatta M, Yamada S, et al. Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol 2005 Aug;79(15):9926-32 [Abstract]

* Sidwell RW, Barnard DL, Day CW, et al. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob Agents Chemother 2007 Mar;51(3):845-51 [Abstract]

* Siembieda J, Johnson CK, Boyce W, et al. Risk for avian influenza virus exposure at human-wildlife interface. Emerg Infect Dis 2008 Jul (published online Jun 6) [Full text]

* Simmons C, Farrar J. Insights into inflammation and influenza. N Engl J Med 2008 Oct 9;359(15):1621-3 [Extract]

* Simmons CP, Bernasconi NL, Suguitan AL Jr, et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med 2007 May;4(5):e178 [Full text]

* Skeik N, Jabr FI. Influenza viruses and the evolution of avian influenza virus H5N1. Int J Infect Dis 2007 (published online Oct 4) [Abstract]

* Skowronski DM, Li Y, Tweed SA, et al. Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ 2007 Jan 2;176(1):47-53 [Full text]

* Smallman-Raynor M, Cliff AD. Avian influenza A (H5N1) age distribution in humans. (Letter) Emerg Infect Dis 2007 Mar;13(3) (published online Feb 2) [Full text]

* Smith BW, Kay VS, Hoyt TV, et al. Predicting the anticipated emotional and behavioral responses to an avian flu outbreak. Am J Infect Control 2009 (published online Jan 5) [Abstract]

* Smith GJD, Fan XH, Wang J, et al. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci 2006 (published online Oct 30) [Abstract]

* Smith JR, Wood SC. Travellers need immediate access to Tamiflu when entering areas at risk from avian or seasonal influenza. Travel Med Infect Dis 2007 (published online Oct 31) [Abstract]

* Smith PW, Anderson AO, Christopher GW, et al. Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror 2006 Dec;4(4):351-5 [Abstract]

* Song D, Kang B, Lee C, et al. Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis 2008 May (published online Mar 28) [Full text]

* Song D, Lee C, Kang B, et al. Experimental infection of dogs with avian-origin canine influenza A virus (H3N2). Emerg Infect Dis 2009 Jan;15(1):56-8 [Full text]

* Song H, Nieto GR, Perez DR. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 2007 Sep;81(17):9238-48 [Abstract]

* Song MS, Oh TK, Moon HJ, et al. Ecology of H3 avian influenza viruses in Korea and assessment of their pathogenic potentials. J Gen Virol 2008 Apr;89(4):949-57 [Abstract]

* Songserm T, Amonsin A, Jam-on R, et al. Fatal avian influenza A H5N1 in a dog. Emerg Infect Dis 2006 Nov;12(11) (published online Oct 10) [Full text]

* Songserm T, Amonsin A, Jam-on R, et al. Avian influenza H5N1 in naturally infected domestic cat. Emerg Infect Dis 2006 Apr; 12(4) [Full text]

* Songserm T, Jam-on R, Sae-Heng N, et al. Domestic ducks and H5N1 influenza epidemic, Thailand. Emerg Infect Dis 2006 Apr;12(4):575-81 [Full text]

* Southwell BG, Hwang Y, Torres A. Avian influenza and US TV news. (Letter) Emerg Infect Dis 2006 Nov;12(11) (published online Oct 13) [Full text]

* Spackman E, Swayne DE, Suarez DL, et al. Characterization of low-pathogenicity H5N1 avian influenza viruses from North America. J Virol 2007 Nov;81(21):11612-9 [Abstract]

* Steel J, Lowen AC, Mubareka S, et al. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog 2009 Jan 2;5(1):e1000252 [Full text]

* Stegeman A, Bouma A, Elbers AR, et al. Avian influenza A virus (H7N7) epidemic in the Netherlands in 2004: course of the epidemic and effectiveness of control measures. J Infect Dis 2004 Dec 15;190(12):2088-95 [Abstract]

* Stelzer-Braid S, Escott R, Baleriola C, et al. Proficiency of nucleic acid tests for avian influenza viruses, Australasia. Emerg Infect Dis 2008 Jul (published online May 28) [Full text]

* Stephenson I, Bugarini R, Nicholson KG, et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 2005 Apr 15;191(8):1210-5 [Abstract]

* Stephenson I, Das RG, Wood JM, et al. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: An international collaborative study. Vaccine 2007 May 16;25(20):4056-63 [Abstract]

* Stephenson I, Nicholson KG, Hoschler K, et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. (Letter) N Engl J Med 2008 Oct 9;359(15):1631-3 [Full text]

* Stevens J, Blixt O, Chen LM, et al. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol 2008 (published online Apr 11) [Abstract]

* Stevens J, Blixt O, Tumpey TM, et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006 Apr 21;312(5772):404-10 [Full text]

* Stohr K. Avian influenza and pandemics: research needs and opportunities. (Editorial) N Engl J Med 2005 Jan 27;352(4):405-7 [Extract]

* Suarez DL, Senne DA, Banks J, et al. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis 2004 Apr;10(4):693-9 [Full text]

* Subbarao K, Luke C. H5N1 viruses and vaccines. PLoS Pathog 2007 Mar;3(3):e40 [Full text]

* Suder G, Inthavong S. New health risks and sociocultural contexts: bird flu impacts on consumers and poultry businesses in Lao PDR. Risk Analysis 2008 Feb;28(1):1-12 [Abstract]

* Suetens C, Snacken R, Hanquet G, et al. Eagles testing positive for H5N1 imported illegally into Europe from Thailand. Eurosurveillance Weekly 2004 Oct 28;8(44) [Full text]

* Suguitan AL Jr, McAuliffe J, Mills KL, et al. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 2006 Sep;3(9) [Full text]

* Suwannakarn K, Chutinimitkul S, Payungporn S, et al. Assay to detect H5N1 oseltamivir resistance. (Letter) Emerg Infect Dis 2006 Dec;12(12) (published online Nov 15) [Full text]

* Swaminathan A, Martin R, Gamon S, et al. Personal protective equipment and antiviral drug use during hospitalization for suspected avian or pandemic influenza. Emerg Infect Dis 2007 Oct;13(10):1541-7 [Full text]

* Swayne D, Beck JR. Experimental study to determine if low-pathogenicity and high-pathogenicity avian influenza viruses can be present in chicken breast and thigh meat following intranasal virus inoculation. Av Dis 2005 Mar;49(1):81-5 [Abstract]

* Swayne DE, Kapczynski D. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev 2008 Oct;225(1):312-31 [Abstract]

* Sylte MJ, Hubby B, Suarez DL. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 2007 May 10;25(19):3763-72 [Abstract]

* Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007 Mar;81(6):2763-44 [Abstract]

* Takeuchi MT. Avian influenza risk communication, Thailand. (Letter) Emerg Infect Dis 2006 Jul;12(7) [Full text]

* Tam DKP, Lee S, Lee SS. Impact of SARS on avian influenza preparedness in healthcare workers. Infection 2007 (published online Sep 19) [Abstract]

* Tam DKP, Lee SS, Lee S. Impact of severe acute respiratory syndrome and the perceived avian influenza epidemic on the increased rate of influenza vaccination among nurses in Hong Kong. Infect Control Hosp Epidemiol 2008;29 (published online Jan 18) [Abstract]

* Tam JS. Influenza A (H5N1) in Hong Kong: an overview. Vaccine 2002 May 15;20 Suppl 2:S77-81 [Abstract]

* Tambyah PA. Update on influenza antivirals. Respirology 2008 Mar;13(s1):S19-21 [Full text]

* Tambyah PA. Update on influenza vaccines. Respirology 2008 Mar;13(s1):S41-3 [Full text]

* Tang JW, Ngai KLK, Chan PKS. Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans. J Med Virol 2008 Nov;80(11):1992-6 [Abstract]

* Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. (Letter) Nature 2005;Oct 6;437(7060):889-93 [Full text]

* Temperton NJ, Hoschler K, Major D, et al. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Virus 2007 (published online Jul 26) [Full text]

* Ten Eyck RP. Ability of regional hospitals to meet projected avian flu pandemic surge capacity requirements. J Prehosp Disaster Med 2008 Mar-Apr;23(2):103-12 [Abstract]

* Thanawongnuwech R, Amonsin A, Tantilertcharoen R, et al. Probable tiger-to-tiger transmission of avian influenza H5N1. Emerg Infect Dis 2005 May 11(5) [Full text]

* The Global Influenza Programme. Expert consultation on diagnosis of H5N1 avian influenza infections in humans. Influenza Other Resp Viruses 2007 Jul;1(4):131-8 (available online Nov 5) [Full text]

* Thitithanyanont A, Engering A, Ekchariyawat P, et al. High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol 2007 Oct 15;179(8):5220-7 [Abstract]

* Thomas C, King DJ, Swayne DE. Thermal inactivation of avian influenza and Newcastle disease viruses in chicken meat. J Food Prot 2008 Jun;71(6):1214-222 [Abstract]

* Thomas C, Swayne DE. Thermal inactivation of H5N1 high pathogenicity avian influenza virus in naturally infected chicken meat. J Food Prot 2007 Mar;70(3):674-80 [Abstract]

* Thorson A, Petzold M, Chuc NTK, et al. Is exposure to sick or dead poultry associated with flulike illness? Arch Intern Med 2006 Jan 9;166(1):119-23 [Abstract]

* Tiensin T, Chaitaweesub P, Songserm T, et al. Highly pathogenic avian influenza H5N1, Thailand, 2004. Emerg Infect Dis 2005 Nov;11(11):1664-72 [Full text]

* Tiensin T, Nielen M, Vernooij H, et al. Transmission of the highly pathogenic avian influenza virus H5N1 within flocks during the 2004 epidemic in Thailand. J Infect Dis 2007 Dec 1;196(11):1679-84 [Full text]

* Tompkins SM, Zhao Z-S, Lo C-Y, et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 2007 Mar;13(3) (published online Feb 15) [Full text]

* Toro H, Tang DC, Suarez DL, et al. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine 2007 Apr 12;25(15):2886-91 [Abstract]

* Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza (H5N1) in 10 patients in Vietnam. N Engl J Med 2004 Mar 18;350(12):1179-88 (See also Klempner below) [Abstract]

* Treanor JJ, Campbell JD, Zangwill KM, et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006 Mar 30;354(13):1343-51 [Full text]

* Treanor JJ. Avian influenza: exploring all the avenues. (Editorial) Ann Intern Med 2006 Oct 17;145(8) (early online publication) [Full text - See also Luke above]

* Treanor JJ. Influenza Virus. In: Mandell GL, Douglas RG, Bennett JE, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Ed 6. Philadelphia: Elsevier, 2005

* Truscott J, Garske T, Chis-Ster I, et al. Control of a highly pathogenic H5N1 avian influenza outbreak in the GB poultry flock. Proc R Soc B 2007 (published online Jul 20) [Abstract]

* Tsiodras S, Kelesidis T, Kelesidis I, et al. Human infections associated with wild birds. J Infect 2007 (published online Dec 21) [Abstract]

* Tsiodras S, Mooney JD, Hatzakis A. Role of combination antiviral therapy in pandemic influenza and stockpiling implications. BMJ 2007 Feb 10;334(7588):293-4 [Abstract]

* Tsukamoto K, Ashizawa H, Nakanishi K, et al. Subtyping of avian influenza viruses H1 to H15 on the basis of hemagglutinin genes by PCR assay and molecular determination of pathogenic potential. J Clin Microbiol 2008 Sep;46(9):3048-55 [Abstract]

* Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005 Oct 7;310(5745):77-80 [Abstract]

* Tumpey TM, Garcia-Sastre A, Mikulasova A, et al. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci 2002 Oct 15;99(21):13849-54 [Abstract]

* Twu KY, Kuo RL, Marklund J, et al. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol 2007 Aug;81(15):8112-21 [Abstract]

* Uchida Y, Mase M, Yoneda K, et al. Highly pathogenic avian influenza virus (H5N1) isolated from whooper swans, Japan. Emerg Infect Dis 2008 (published online Jul 29) [Abstract]

* Uiprasertkul M, Kitphati R, Puthavathana P, et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis 2007 May;13(5) (published online Apr 6) [Full text]

* Uiprasertkul M, Puthavathana P, Sangsiriwut K, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005 July;11(7) [Full text]

* UN System Influenza Coordinator & World Bank. Responses to avian influenza and state of pandemic readiness: fourth global progress report. Released Oct 15, 2008 [Full text]

* UN System Influenza Coordinator & World Bank. Responses to avian influenza and state of pandemic readiness: third global progress report. Released Nov 29, 2007 [Full text]

* Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005 Jan 27;352(4):333-40 [Full text]

* US Department of State. Fact sheet: Avian influenza A (H5N1) and pandemic influenza. Updated Sep 27, 2008 [Full text]

* US Department of State. Medical information for Americans traveling abroad [Webpage]

* Uscher-Pines L, Omer SB, Barnett DJ, et al. Priority setting for pandemic influenza: an analysis of national preparedness plans. PLoS Med 2006 Oct;3(10) (published online Oct 17) [Full text]

* USDA. Efforts and response to avian influenza in the United States Transcript of Oct 26, 2005, technical briefing [Press release with links to webcast and transcript]

* USDA/APHIS. Agricultural Bioterrorism Protection Act of 2002: Possession, use, and transfer of biological agents and toxins. Final Rule 7 CFR Part 331 and 9 CFR Part 121. Fed Reg 2005 Mar 18;70(52):13242-92 [Full text]

* USDA/APHIS. Highly pathogenic avian influenza. Mar 2004 [Full text]

* USDA/APHIS. Questions and answers on the Agricultural Bioterrorism Protection Act of 2002: Possession, use, and transfer of select agents and toxins. APHIS factsheet. May 2005 [Full text]

* USDA/FSIS. Draft interagency risk assessment for the public health impact of highly pathogenic avian influenza virus (HPAIV) in poultry, shell eggs, and egg products. Nov 2008 [Links to report, summary, etc]

* USDA/FSIS. FSIS seeks comments on draft risk assessment for the public health impact of highly pathogenic avian influenza virus in poultry, shell eggs, and egg products. Dec 2, 2008, press release [Full text]

* Uyeki TM, Bresee JS. Detecting human-to-human transmission of avian influenza A (H5N1). (Letter) Emerg Infect Dis 2007 Dec;13(12):1969-70 (published online Nov 6) [Full text]

* Uyeki TM, Chong YH, Katz JM, et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China, 1999. Emerg Infect Dis 2002 Feb;8(2):154-9 [Full text]

* Uyeki TM. Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology 2008 Mar;13(s1):S2-9 [Full text]

* Vahlenkamp TW, Harder TC, Giese M, et al. Protection of cats against lethal influenza H5N1 challenge infection. J Gen Virol 2008 Apr;89(4):968-74 [Abstract]

* Vajo Z, Kosa L, Szilvasy I, et al. Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine. Pediatr Infect Dis J 2008 (published online Oct 30) [Abstract]

* Vajo Z, Kosa L, Visontay I, et al. Inactivated whole virus influenza A (H5N1) vaccine. (Letter) Emerg Infect Dis 2007 May;13(5) (published online Mar 29) [Full text]

* Vallat B. Avian influenza epizootie: where do we stand in 2007. 2007 Snowdon Lecture delivered Jul 11, 2007 [Links to slides and video]

* Van Beest Holle MD, Meijer A, Koopmans M, et al. Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003. Eurosurveillance Monthly 2005 Dec;10(12) [Full text]

* Van Borm S, Thomas I, Hanquet G, et al. Highly pathogenic H5N1 influenza virus in smuggled Thai eagles, Belgium. Emerg Infect Dis 2005 May 11(5) [Full text]

* van Boven M, Koopmans M, van Beest Holle MD, et al. Detecting emerging human transmissibility of avian influenza virus in human households. PLoS Comp Biol 2007 Jul;3(7):e145 [Full text]

* van der Goot JA, Koch G, de Jong MC, et al. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc Natl Acad Sci 2005 Dec 13;102(50:18141-6 [Abstract]

* van der Goot JA, van Boven M, Stegeman A, et al. Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine. Virology 2008 Dec 5;382(1):91-7 [Abstract]

* van der Laan JW, Herberts C, Lambkin-Williams R, et al. Animals models in influenza vaccine testing. Expert Rev Vaccines 2008 Aug;7(6):783-93 [Abstract]

* van Gils JA, Munster VJ, Radersma R, et al. Hampered foraging and migratory performance in swans infected with low-pathogenic avian influenza A virus. PLoS One 2007 Jan 31;2(1):e184 [Full text]

* Van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science 2006 (published online Mar 23) [Abstract]

* van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science 2006 Apr 21;312(5772):399 [Full text]

* van Riel D, Munster VJ, de Wit E, et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007 (published online Aug 23) [Abstract]

* Veits J, Romer-Oberdorfer A, Helferich D, et al. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine Mar 20;26(13):1688-96 [Abstract]

* Veits J, Wiesner D, Fuchs W, et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci 2006 May 23;103(2):8197-202 [Abstract]

* Vijaykrishna D, Bahl J, Riley S, et al. Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog 2008 Sep 26;4(9):e1000161 [Full text]

* Vong S, Coghlan B, Mardy S, et al. Low frequency of poultry-to-human H5N1 virus transmission, Southern Cambodia, 2005. Emerg Infect Dis 2006 Oct;12(10) [Full text]

* Vong S, Ly S, Mardy S, et al. Environmental contamination during influenza A virus (H5N1) outbreaks, Cambodia, 2006. Emerg Infect Dis 2008 Aug;14(8):1303-5 [Full text]

* Voyles BA. Orthomyxoviruses. In: The biology of viruses. Ed 2. New York, NY: McGraw-Hill, 2002:147

* Wahlgren J, Waldenstrom J, Sahlin S, et al. Gene segment reassortment between American and Asian lineages of avian influenza virus from waterfowl in the Beringia area. Vector-Borne Zoonotic Dis 2008 (published online Jun 18) [Abstract]

* Wallace LA, McAulay KA, Douglas JD, et al. Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group. J Infect 1999 Nov;39(3):221-6 [Abstract]

* Wallace RG, Fitch WM. Influenza A H5N1 immigration is filtered out at some international borders. PLoS ONE 2008 Feb 27;3(2):e1697 [Full text]

* Wallensten A, Munster VJ, Latorre-Margalef N, et al. Surveillance of influenza A virus in migratory waterfowl in northern Europe. Emerg Infect Dis 2007 Mar;13(3) (published online Feb 21) [Full text]

* Wan H, Perez DN. Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells. J Virol 2007 May;81(10):5181-91 [Abstract]

* Wan H, Sorrell EM, Song H, et al. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE 2008 Aug 13;3(8):e2923 [Full text]

* Wang G, Zhan D, Li L, et al. H5N1 avian influenza re-emergence of Lake Qinghai: phylogenetic and antigenic analyses of the newly isolated viruses and roles of migratory birds in virus circulation. J Gen Virol 2008 Mar;89(3):697-702 [Full text]

* Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 2008 Apr 25;371(9622):1427-34 [Abstract]

* Wang J, Vijaykrishna D, Duan L, et al. Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern China. J Virol 2008 Apr;82(7):3405-14 [Abstract]

* Wang M, Di B, Zhou D-H, et al. Food markets with live birds as source of avian influenza. Emerg Infect Dis 2006 Nov;12(11) (published online Sep 27) [Full text]

* Wang M, Lamberth K, Harndahl M, et al. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 2007 Apr 12;25(15):2823-31 [Abstract]

* Ward MP, Maftei D, Apostu C, et al. Estimation of the basic reproductive number (R0) for epidemic, highly pathogenic avian influenza subtype H5N1 spread. Epidemiol Infect 2008 (published online Jun 18) [Abstract]

* Ward MP, Maftei DN, Apostu CL, et al. Association between outbreaks of highly pathogenic avian influenza subtype H5N1 and migratory waterfowl (Family Anatidae) populations. Zoonoses Public Health 2008 (published online Sep 11) [Abstract]

* Watanabe T, Watanabe S, Kim JH, et al. Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. J Virol 2008 March;82(5):2486-92 [Abstract]

* Weber TP, Stilianakis NI. Ecologic immunology of avian influenza (H5N1) in migratory birds. Emerg Infect Dis 2007 Aug;13(8):1139-43 [Full text]

* Weber TP, Stilianakis NI. Migratory birds, the H5N1 influenza virus and the scientific method. (Commentary) Virol J 2008;5:57 (published online May 9) [Abstract]

* Webster R, Peiris M, Chen H, et al. H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 2006 Jan;12(1) [Full text]

* Webster RG, Govorkova EA. H5N1 influenza--continuing evolution and spread. N Engl J Med 2006 Nov 23;355(21):2174-7 [Full text]

* Webster RG. Predictions for future human influenza pandemics. J Infect Dis 1997 Aug;176(Suppl 1):S14-9 [Full text]

* Wei CJ, Xu J, Kong WP, et al. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 2008 Jul;82(13):6200-8 [Abstract]

* Weinberg A. Evaluation of three influenza a and B rapid antigen detection kits?update. Clin Diagn Lab Immunol 2005 Aug;12(8):1010 [Listing with link]

* Wetherall NT, Trivedi T, Zeller J, et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 2003 Feb;41(2): [Full text]

* White House. Executive order: amendment to Executive Order 13295 relating to certain influenza viruses and quarantinable communicable diseases. Apr 1, 2005 [Full text - See also CDC Q & A above]

* WHO (Writing Committee of the Second WHO Consultation on Clinical Aspects of Human Infection with Avian Influenza A [H5N1] Virus). Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008 Jan 17;358(3):261-73 [Full text]

* WHO (Writing Committee of WHO Consultation on Human Influenza A/H5). Avian influenza A (H5N1) infection in humans. N Engl J Med 2005 Sep 29;353(13):1374-85 [Full text]

* WHO. A summary of tracking avian influenza A (H5N1) specimens and viruses shared with WHO from 2003 to 2007. Released Jan 21, 2008 [Full text]

* WHO. Advice on use of oseltamivir. Mar 17, 2006 [Full text]

* WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as human vaccines. Updated Sep 29, 2008 [Full text]

* WHO. Assessment of risk to human health associated with outbreaks of highly pathogenic H5N1 avian influenza in poultry. May 14 [Full text]

* WHO. Avian influenza ("bird flu"): fact sheet. Jan 2006 [Full text]

* WHO. Avian influenza and the pandemic threat in Africa: risk assessment for Africa. Oct 28, 2005 [Full text]

* WHO. Avian influenza food safety issues. Nov 2005 [Full text]

* WHO. Avian influenza surveillance [Webpage]

* WHO. Avian influenza, including influenza A (H5N1), in humans; WHO interim infection control guideline for health care facilities. Revised May 10, 2007 [Full text]

* WHO. Avian influenza: assessing the pandemic threat. Jan 2005 [Full text]

* WHO. Avian influenza: food safety issues. Dec 5, 2005 [Full text]

* WHO. Avian influenza: significance of mutations in the H5N1 virus. Feb 20, 2006 [Full text]

* WHO. Checklist for influenza pandemic preparedness planning. 2005 [Full text]

* WHO. Clinical management of human infection with avian influenza A (H5N1) virus. Aug 15, 2007 [Full text]

* WHO. Development of a vaccine effective against avian influenza H5N1 infection in humans: update 4. Jan 20, 2004 [Webpage]

* WHO. Donation of three million treatments of oseltamivir to WHO to help early response to an emerging influenza pandemic [Webpage]

* WHO. Epidemic and Pandemic Alert and Response (EPR). [Webpage]

* WHO. Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly Epidemiol Rec 2006 Jun 30;81(26):249-56 [Full text]

* WHO. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005 Oct;11(10) [Full text]

* WHO. Food safety: avian influenza A(H5N1) in humans and in poultry in Asia. Jan 24, 2004 [Web page]

* WHO. Geographical spread of H5N1 avian influenza in birds: update 28. Aug 18, 2005 [Full text]

* WHO. Guidelines for global surveillance of influenza A/H5 [Webpage]

* WHO. Guidelines for the use of seasonal influenza vaccine in humans at risk of H5N1 infection. Published Jan 30, 2004 [Web page]

* WHO. Human cases of avian influenza A(H5N1) in North-West Frontier Province, Pakistan, October-November 2007. Wkly Epidemiol Rec 2008 Oct 3;83(40):359-64 [Full text; go to 3rd page of PDF]

* WHO. Human cases of influenza A(H5N1) infection, in eastern Turkey, December 2005 - January 2006. WER 2006 Oct 27;81(3):410 [Full text]

* WHO. Infection control recommendations for avian influenza in health-care facilities. Apr 2008 [Full text]

* WHO. Infection control recommendations for avian influenza in health-care. Apr 19, 2006 (concise guide based on full recommendations updated Feb 9, 2006) [Full text]

* WHO. Influenza A (H5N1): WHO interim infection control guidelines for health care facilities. Mar 11, 2004 [Webpage]

* WHO. Inter-country consultation: influenza A/H5N1 in humans in Asia. May 6-7, 2005; Manila, The Phillipines. [Full text]

* WHO. Laboratory study of H5N1 viruses in domestic ducks: main findings. Oct 29, 2004 [Full text - Summary of upcoming research]

* WHO. Notice about avian influenza A (H5N1) in Asia and travel during the Lunar New Year. Released Dec 29, 2005 [Full text]

* WHO. Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile. Released May 16, 2008 [Full text]

* WHO. Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness. Feb 19, 2004 [Full text]

* WHO. Responding to the avian influenza pandemic threat: recommended strategic actions. Released Sep 2, 2005 [Full text]

* WHO. Review of latest available evidence on risks to human health through potential transmission of avian influenza (H5N1) through water and sewage. Mar 24, 2006 [Full text]

* WHO. Summary of the second WHO consultation on clinical aspects of human infection with avian influenza A(H5N1) virus, 19-21 March, 2007, Antalya, Turkey. Released Apr 19, 2007 [Full text]

* WHO. Towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses. Released Aug 7, 2007 [Full text]

* WHO. Update: WHO-confirmed human cases of avian influenza A(H5N1) infection, 25 November 2003 - 24 November 2006. Wkly Epidemiol Rec 2007 Feb 9;82(6):41-8 [Full text]

* WHO. WHO case definitions for human infections with influenza A(H5N1) virus. Aug 29, 2006 [Full text]

* WHO. WHO guidance on public health measures in countries experiencing their first outbreaks of H5N1 avian influenza. Oct 2005 [Full text]

* WHO. WHO guidelines for investigation of human cases of avian influenza A(H5N1). Jan 2007 [Full text]

* WHO. WHO inter-country consultation: influenza A/H5N1 in humans in Asia. Manila May 6-7, 2005 [Full text]

* WHO. WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus. May 2006 [Summary with link to full text]

* WHO. WHO recommendations relating to travellers coming from and going to countries experiencing outbreaks of highly pathogenic H5N1 avian influenza. Nov 2005 [Full text]

* WHO/OIE/FAO H5N1 Evolution Working Group. Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). (Online report) Emerg Infect Dis 2008 Jul;14(7):e1 [Full text]

* WHO: INFOSAN. Highly pathogenic H5N1 avian influenza outbreaks in poultry and in humans: food safety implications [Webpage]

* Widjaja L, Krauss SL, Webby RJ, et al. Matrix gene of influenza A viruses isolated from wild aquatic birds: ecology and emergence of influenza A viruses. J Virol 2004 Aug;78(16):8771-9 [Abstract]

* Winker K, McCracken KG, Gibson DD, et al. Movements of birds and avian influenza from Asia into Alaska. Emerg Infect Dis 2007 Apr 13(4) (published online Mar 2) [Full text]

* Winker K, Spackman E, Swayne DE. Rarity of influenza A virus in spring shorebirds, southern Alaska. (Letter) Emerg Infect Dis 2008 Aug;14(8):1314-5 [Full text]

* Wong JP, Christopher ME, Salazar AM, et al. Nucleic acid-based drugs against seasonal and avian influenza viruses. Vaccine 2007 Apr 20;25(16):4175-8 [Abstract]

* Wong SSY, Yuen KY. Avian influenza virus infections in humans. Chest 2006;129(1):156-68 [Full text]

* Wong SSY, Yuen KY. Human infection by avian influenza A h5n1. Hong Kong Med J 2005;11(3):189-99 [Full text]

* World Bank. Avian and human influenza: financing needs and gaps. Jan 12, 2006 [Full text]

* Wu WL, Chen Y, Wang P, et al. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol 2008 Feb 15;82(4):1798-807 [Abstract]

* Wuethrich B. Infectious disease: an avian flu jumps to people. Science 2003 Mar 7;299(5612):1504

* Xu KM, Li KS, Smith GJ, et al. Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005. J Virol 2007 Mar;81(6):2635-45 [Abstract]

* Xu KM, Smith GJD, Bahl J, et al. The genesis and evolution of H9N2 influenza viruses in poultry from Southern China, 2000 to 2005. J Virol 2007 Oct;81(19):10389-401 [Abstract]

* Xu X, Jin M, Yu Z, et al. Latex agglutination test for monitoring antibodies to avian influenza virus subtype H5N1. J Clin Microbiol 2005 Apr;43(4):1953-5 [Abstract]

* Yamada T, Dautry A, Walport M. Ready for avian flu? (Commentary) Nature 2008 Jul 10;454(7201):162 [Full text]

* Yamamoto Y, Nakamura K, Okamatsu M, et al. Detecting avian influenza virus (H5N1) in domestic duck feathers. (Letter) Emerg Infect Dis 2008 Oct;14(10):1671 [Full text]

* Yamamoto Y, Nakamura K, Okamatsu M, et al. Avian influenza virus (H5N1) replication in feathers of domestic waterfowl. Emerg Infect Dis 2008 Jan;14(1):149-51 (published online Dec 21) [Full text]

* Yan J, Lu Y, Mao H, et al. Pathogenic and molecular characterization of the H5N1 avian influenza virus isolated from the first human case in Zhejiang province, China. Diagn Microbiol Infect Dis 2007 Aug;58(4):399-405 [Abstract]

* Yang Y, Halloran ME, Sugimoto J, et al. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis 2007 Sep;13(9):1348-53 [Full text]

* Yang ZY, Wei CJ, Kong WP, et al. Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding. Science 2007 Aug 10;317(5839):825-8 [Abstract]

* Yao L, Korteweg C, Hsueh W, et al. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J 2007 (published online Oct 9) [Abstract]

* Yen HL, Ilyushina NA, Salomon R, et al. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol 2007 Nov;81(22):12418-26 [Abstract]

* Yen HL, Lipatov AS, Ilyushina NA, et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol 2007 Jul;81(13):6890-8 [Abstract]

* Yen HL, Monto AS, Webster RG, et al. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 2005 Aug 15;192(4):665-72 [Abstract]

* Yingst SL, Saad MD, Felt SA. Qinghai-like H5N1 from domestic cats, Northern Iraq. (Letter) Emerg Infect Dis 2006 Aug;12(8) [Full text]

* Yoon KJ, Cooper VL, Schwartz KJ, et al. Influenza virus infection in racing greyhounds. Emerg Infect Dis 2005 Dec;11(12):1974-5

* Yu H, Feng Z, Zhang X, et al. Human influenza A (H5N1) cases, urban areas of People's Republic of China, 2005-2006. Emerg Infect Dis 2007 Jul;13(7):1061-4 [Full text]

* Yu H, Gao Z, Feng Z, et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS ONE 2008 Aug;3(8):e2985 [Full text]

* Yu Z, Song Y, Zhou H, et al. Avian influenza (H5N1) virus in waterfowl and chickens, central China. Emerg Infect Dis 2007 May;13(5) (published online Apr 11) [Full text]

* Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351(9101):467-71 [Abstract]

* Yun NE, Linde NS, Zacks MA, et al. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus A/Vietnam/1203/04 (H5N1). Virology 2008 Apr 25;374(1):198-209 [Abstract]

* Zangwill KM, Treanor JJ, Campbell JD, et al. Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans. J Infect Dis 2008 (published online Jan 29) [Abstract]

* Zarocostas J. Nations signal support for WHO to stockpile H5N1 vaccine. BMJ 2007 May 5;334(7600):925 [Extract]

* Zeng H, Goldsmith C, Thawatsupha P, et al. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells. J Virol 2007 Nov;81(22):12439-49 [Abstract]

* Zhang G, Shoham D, Gilichinsky D, et al. Evidence of influenza A virus RNA in Siberian lake ice. J Virol 2006 Dec;80(24):12229-35 [Abstract]

* Zhang P, Tang Y, Liu X, et al. Characterization of H9N2 influenza viruses isolated from vaccinated flocks in an integrated broiler chicken operation in eastern China during a 5 year period (1998-2002). J Gen Virol 2008 Dec;89(12):3102-12 [Abstract]

* Zhao Y, Lu M, Lau LT, et al. Neutrophils may be a vehicle for viral replication and dissemination in human H5N1 avian influenza. Clin Infect Dis 2008 (published online Nov 6) [Abstract]

* Zhao ZM, Shortridge KF, Garcia M, et al. Genotypic diversity of H5N1 highly pathogenic avian influenza viruses. J Gen Virol 2008 Sep;89(9):2182-93 [Abstract]

* Zhong NS, Zeng GQ. Pandemic planning in China: applying lessons from severe acute respiratory syndrome. Respirology 2008 Mar;13(s1):S33-5 [Full text]

* Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. (Letter) N Engl J Med 2007 Oct 4;357(14):1450-1 [Extract]

* Zhou J, Law HK, Cheung CY, et al. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 2006 Jul 1;194(1):61-70 [Abstract]

* Zou S, Han J, Wen L, et al. Human influenza A virus (H5N1) detection by a novel multiplex PCR typing method. J Clin Microbiol 2007 Jun;45(6):1889-92 [Abstract]